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To survive, neurons and other eukaryotic cells must rapidly repair (seal) 
plasmalemmal damage.  Such repair occurs by an accumulation of intracellular vesicles 
at or near the plasmalemmal disruption.  Diacylglycerol (DAG)-dependent and cAMP-
dependent proteins are involved in many vesicle trafficking pathways.  Although recent 
studies have implicated the signaling molecule cAMP in sealing, no study has 
investigated how DAG and DAG-dependent proteins affect sealing and, whether 
pharmacological inhibition of such proteins could promote immediate repair of damaged 
mammalian axons.  To this end, I investigated the role of DAG, protein kinase C (PKC) 
and other DAG-activated proteins in plasmalemmal sealing in B104 neurons in vitro and 
rat sciatic nerves in vivo.  Using dye exclusion to assess Ca
2+
-dependent vesicle-mediated 
sealing of transected neurites of individually identifiable rat hippocampal B104 cells, I 
now report that, compared to non-treated controls, sealing probabilities and rates are 
increased by DAG and cAMP analogs that activate PKC and Munc13-1, and protein 
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kinase A (PKA).  Sealing is decreased by inhibiting DAG-activated novel protein kinase 
C isozymes η (nPKCη) and θ (nPKCθ) and, Munc13-1, the PKC effector myristoylated 
alanine rich PKC substrate (MARCKS) or phospholipase C (PLC).  DAG-increased 
sealing is prevented by inhibiting MARCKS or PKA.  Sealing probability is further 
decreased by simultaneously inhibiting nPKCη, nPKCθ and PKA.  Extracellular Ca
2+
, 
DAG or cAMP analogs do not affect this decrease in sealing.  I also report that applying 
inhibitors of nPKC and PKA to rat sciatic axons crush-severed in vivo under 
physiological calcium, do not promote immediate repair by polyethylene glycol (PEG), 
as assessed by compound action potential conduction and dye diffusion through crush 
sites.  These and other data suggest that DAG increases sealing through MARCKS and 
that nPKCη, nPKCθ and PKA are all required to seal plasmalemmal damage in B104 
neurons, and likely all eukaryotic cells. 
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Chapter 1: General Introduction 
IMPORTANCE OF PLASMALEMMAL SEALING 
 Cells that do not repair (seal) plasma membrane (plasmalemmal) damage, do not 
survive (McNeil, 1993, 2000; Nguyen et al., 2005).  For victims of neurotrauma, such as 
peripheral nerve crush injury (PNCI) or stroke, loss of nerve cells (neurons) directly 
correlates with loss of functional behaviors and even paralysis.  Furthermore, in 
mammals, regaining lost functional behaviors is dependent upon axonal regeneration; 
which occurs from a surviving proximal axonal end that slowly grows neuritic processes 
at 1-2mm/day that often do not re-establish original synapses (Britt et al., 2010).  Thus, 
after PNCI or stroke, plasmalemmal sealing is a critical first step for neurons (Krause et 
al., 1994; Steinhardt et al., 1994; Bittner and Fishman, 2000; Detrait et al., 2000; Yoo et 
al., 2003; Spaeth et al., 2010), because only surviving neurons are capable of axonal 
regeneration, which correlates with increased functional behavior recovery (Britt et al., 
2010; Bittner et al., 2012). 
Thus, research that provides fundamental insights into the cellular mechanisms 
and pathways that normally promote sealing in eukaryotic cells should have direct and 
indirect implications on axonal repair and regeneration after traumatic central or 





Vesicle-mediated repair theory states that sealing of plasmalemmal damage is a 
Ca
2+
-induced, vesicle-mediated process that drives accumulation of vesicles at sites of 
damage (either small holes or complete transections) to produce a seal that restores ionic 
permeabilities to pre-lesion levels within 10-20 minutes (Fig. 1; Spaeth et al., 2010).  
However, little is known of the cellular mechanisms and pathways of sealing.  Prior to 
1994, textbooks (Kandel, et al., 1990) and research publications (Spira et al., 1993) 
assumed that minor plasmalemmal damage was sealed by the spreading of plasmalemmal 
lipids and complete cellular or axonal transection was sealed by collapse and fusion of 
plasmalemmal leaflets.  Krause et al. (1994) showed that both lesion types in several 
invertebrate axons sealed by an accumulation of membrane-bound structures (mostly 
vesicles).  Steinhardt et al. (1994) reported similar sealing mechanisms in sea urchin eggs 
and mammalian epithelial cells.  These data were the first evidence that sealing is a 
vesicle-mediated process, similar to synaptic transmission and Golgi trafficking, in that 
vesicles fuse with undamaged plasmalemma or one another to form a seal at the damage 
site (Fig. 1). 
More recent data (see Spaeth et al., 2010, for reference of sealing studies) using 
19 different in vivo, ex vivo and in vitro preparations from many phyla from our lab 
(invertebrate giant or mammalian axons), and other labs, including plant cells (Schapire, 
et al., 2009), consistently show that endogenous, naturally-occurring plasmalemmal 
sealing requires various proteins, many of whose isomers are Ca
2+
-dependent and 
involved in membrane trafficking/fusion in neurotransmission and Golgi apparatus 
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(Sudhof, 2007; Sudhof and Rothman, 2009), such as synaptobrevin, syntaxin, 
synaptophilin, synaptotagmin, calpains, protein kinase A (PKA), and protein kinase C 
(PKC) (Krause et al., 1994; Steinhardt et al., 1994; Ballinger et al., 1997; Eddleman et 
al., 2000; Bittner et al., 2000; Bittner and Fishman, 2000; Detrait et al., 2000; Reddy et 
al., 2001; Yoo et al., 2003; Togo, 2004; Nguyen et al., 2005; Spaeth et al., 2010).  Studies 
on sealing have also shown that sealing can be enhanced by promoting the activity of 
endogenous sealing pathways.  For instance, increasing cyclic adenosine monophosphate 
(cAMP) concentration, or specifically activating PKA or Epac via target-specific cAMP 
analogs, all produced similar increases in plasmalemmal sealing (Spaeth et al., 2010).  
However, no study to date has shown that inhibition of any single pathway of sealing 
abolished sealing in that preparation.  That is, vesicle-mediated sealing likely involves 
redundant, parallel pathways initiated by Ca
2+
 influx.  Lastly, data from many different 
preparations from many diverse phyla show that isomers of the same proteins, pathways 
and vesicle interactions are likely involved in plasmalemmal sealing of all eukaryotic 
cells, indicating that such proteins in eukaryotes evolved to repair plasmalemmal damage. 
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Figure 1: Schematic of endogenous, Ca
2+
-dependent, vesicle-mediated sealing: 
Sealing of an axon, in which vesicles form a plug at a partly constricted transection site 
(lesion site) and site of minor plasmalemmal damage (top of axon).  
Endogenous sealing in all eukaryotic cells likely occurs by this mechanism 
(Krause et al., 1994; Steinhardt et al., 1994; Ballinger et al., 1997; Eddleman 
et al., 2000; Bittner and Fishman, 2000; Detrait et al., 2000; Lichstein et al., 
2000; Reddy et al., 2001; Yoo et al., 2003; Spaeth et al., 2010). 
 
DIACYLGLYCEROL (DAG), PKC AND OTHER DAG-ACTIVATED PROTEINS IMPLICATED 
IN SEALING  
 DAG mediates many vesicle-mediated pathways (secretion, neurotransmission, 
trafficking of integral membrane proteins) typically by activating PKC isozymes.  As 
previously mentioned, sealing occurs via vesicle (and other membrane) accumulation at 
sites of plasmalemmal damage.  Togo et al. (2000, 2004, 2006) showed that inhibiting 
classical PKC (cPKC) isozymes with small-molecule inhibitors, Bisindoylmaleimide I 
(Bis I) and Gö6976, decreased sealing, suggesting for the first time that PKC promotes 
sealing in fibroblasts and possibly other eukaryotic cells.  Recently, we demonstrated that 
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novel PKC isozyme η promotes sealing in B104 neurons in vitro (Spaeth et al., 2010).  
Taken together these data suggest that DAG and PKC isozymes are implicated in 
plasmalemmal sealing.  Given these data, I investigated how DAG and which PKC 
isozymes influence endogenous plasmalemmal sealing in B104 cells.  
Diacylglycerol 
 Diacylglycerol (DAG) and inositol trisphosphate (IP3) are two secondary 
messengers produced by hydrolysis of phosphatidyl inositol (4, 5) bisphosphate (PIP2) by 
phospholipase C (PLC) and both play important roles in PKC-dependent signaling. PLC 
is typically activated by G-protein coupled receptors, but can also be activated by 
cleavage by the Ca
2+
-dependent cysteine protease, calpain (Glass et al., 2002; Ray et al., 
2003).  DAG remains in the plasmalemma and is necessary for both recruiting PKC 
isozymes to the plasmalemma and activating them.  IP3 is soluble and diffuses through 
the cytoplasm.  IP3 is bound by inositol trisphosphate ligand-gated Ca
2+
 channels of the 
endoplasmic reticulum (or sarcoplamsic reticulum in muscle cells), inducing release of 
Ca
2+
 from intracellular stores, thus further promoting PKC activity.  Lastly, I have 
recently shown that nPKC isozyme η (requires only DAG for activation) promotes 
sealing in B104 neurons in vitro (Spaeth et al., 2010), suggesting that DAG influences 
plasmalemmal sealing in B104 neurons.  
Protein kinase C (PKC) 
Like PKA (which has been shown to promote sealing in B104 neurons in vitro, 
Spaeth et al., 2010, 2011), PKC isozymes are involved in many vesicle-mediated 
processes in neurons, such as turning of axonal growth cones, transport of beta-1 
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integrins and neurite/dendrite extension (Mikule et al., 2003; Sivasankaran et al., 2004; 
Gatlin et al., 2006; Siskova et al., 2006; Tsai et al., 2007), and are therefore likely 
involved in plasmalemmal sealing.  PKCs are a family of serine/threonine kinases whose 
activity is dependent upon the plasmalemmal lipid, phosphoserine.  The PKC family is 
divided into three groups: classical isozymes (cPKC α, β1, β2, γ) require both calcium 
and DAG for activation, novel isozymes (nPKC δ, ε, η, θ) require only DAG for 
activation and, atypical isozymes (aPKC ι/λ, ζ) require neither calcium nor DAG for 
activation and are thought to be regulated via phosphorylation by other PKC isozymes 
and kinases (Uberall et al., 1997; Larsson, 2006; Park et al., 2007).  The PKC structure 
consists of two parts: a regulatory domain (pseudosubstrate region) that contains binding 
sites for the activators Ca
2+
 and DAG and a catalytic domain.  Atypical PKC isozymes 
have a similar structure to cPKC and nPKC isozymes. 
MARCKS and GAP43 
PKC isozymes regulate many vesicle-mediated processes via phosphorylation of 
downstream targets (effectors).  Because of their roles in axonal growth cone turning and 
dendrite formation some of the most-studied effectors of PKC are growth associated 
protein of 43kDa (GAP43) and myristoylated alanine rich protein kinase C substrate 
(MARCKS).  Of these cytoskeleton associated proteins, GAP43 is exclusively found in 
neurons, whereas MARCKS is expressed in all tissues (Wiederkehr et al., 1997; Frey et 
al., 2000; Korshunova et al., 2006; Laux et al., 2000; Tsai et al., 2007).  GAP43 and 
MARCKS are phosphorylated by various isozymes of PKC at their effector domain (ED) 
(Wiederkehr et al., 1997; Frey et al., 2000; Laux et al., 2000).  GAP43 and MARCKS are 
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proposed to cause cytoskeleton rearrangements by altering the availability of PIP2 along 
the inner leaflet of the plasma membrane for hydrolysis by PLC (Frey et al., 2000; Laux 
et al., 2000).   
As briefly mentioned above, PKC-dependent phosphorylation of MARCKS and 
GAP43 mediates axonal growth cone turning (Mikule et al., 2003), neurite extension 
(Kolkova et al., 2000; Sivasankaran et al., 2004; Tsai et al., 2007) and vesicle mediated 
transport of beta-1 Integrins to the plasma membrane (Siskova et al., 2006; Wiederkehr et 
al., 1997; Miranti, et al., 1999; Frey et al., 2000; Laux et al., 2000; Larsson, 2006). 
MARCKS and GA43 are abundantly expressed in growth cones (Kolkova et al., 2000; 
Gatlin et al., 2006; Korshunova et al., 2006).  These data strongly suggest that PKC and 
PKC-dependent phosphorylation of GAP43 or MARCKS could influence vesicle-
mediated plasmalemmal sealing. 
Munc 13-1 
Like cPKC and nPKC, Munc13-1 (a membrane fusion protein used in 
neurotransmission) contains the DAG binding C1 domain (Brose and Rosenmund, 2002).  





independent vesicular fusion events of the readily releasable pool of vesicles (Basu, et al. 
2007).  Other membrane fusion proteins involved in synaptic transmission also promote 
sealing, such as synaptobrevin, syntaxin, synaptophilin, synaptotagmin. Taken together 
these data suggest that Munc13-1 may be involved in plasmalemmal sealing. 
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PURPOSE OF STUDYING PLASMALEMMAL SEALING WITH REGARDS TO PERIPHERAL 
NERVE CRUSH INJURY AND STROKE 
 A common traumatic peripheral nerve injury in humans is peripheral nerve crush 
injury (PNCI): typically caused by compression of surrounding tissues upon the nerve, 
sometimes completely severing axons within the nerve, resulting in significant behavioral 
deficits (Campbell, 2008).  Stroke is the third leading cause of death in the USA (Roger, 
2006; Janardhan and Qureshi, 2004).  It is well documented that ischemia (oxygen 
glucose deprivation; OGD) and PNCI produce plasmalemmal damage (Rodriguez-
Sinovas, 2005; Campbell, 2008).  Improving the rate and extent of mammalian axonal 
regeneration has been a major research goal for many neuroscientists, because most 
current repair strategies rely on slow (sometimes ineffective) axonal outgrowths from 
surviving neurons to re-innervate target tissues.  Such techniques have slightly improved 
the number and specificity of regenerating axons, but never the time course of behavioral 
recovery (Lago et al., 2007; Kalbermatten et al., 2009), or prevented Wallerian 
degeneration of severed distal axons (Lore et al., 1999; Marzullo et al., 2002; Stavisky et 
al., 2005; Britt et al., 2010). 
Polyethylene glycol 
Severed mammalian axons can be immediately repaired (within 1-2 minutes) 
using the membrane fusogen polyethylene glycol (PEG) (Krause et al., 1991; Stavisky et 
al., 2005; Britt et al., 2010; Bittner et al., 2012).  Briefly, polyethylene glycol (PEG) has 
been used since the 1970s by cell biologists to fuse various cell types and to make cell 
hybrids (Ahkong, 1987).  PEG is an amphipathic molecule able to remove waters of 
hydration from membrane-bound proteins allowing adjacent lipid membranes to flow into 
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one another.  The membrane fusogenic properties of PEG have been advantageously used 
to rapidly and permanently repair peripheral nerve crush- and cut-severance in mammals, 
in vivo (Britt et al., 2010; Bittner et al., 2012). 
Application of PEG to severed axons in hypotonic calcium free physiological 
saline restores axonal morphological continuity and conduction of action potentials 
through the lesion site of invertebrate and vertebrate (rat) axons in vitro and in vivo 
(Krause, 1991; Marzullo, 2002; Stavisky, 2005).  Application of PEG to crush-severed 
sciatic axons significantly increased the rate of functional behavior recovery in crush 
injury animals that received PEG versus crush injury animals that received vehicle 
treatment in vivo (Britt et al., 2010).  It is hypothesized that application of hypotonic 
calcium free saline immediately after crush-severance (prior to PEG), promotes PEG-
fusion by impeding (inhibiting) endogenous sealing in crush-severed axonal ends.  Thus, 
increasing the number of open closely apposed axonal ends for PEG-fusion.   
In my proposal I originally hypothesized that application of compounds that 
inhibit endogenous sealing may be able to impede the effects of endogenous extracellular 
Ca
2+
 influx such that fewer crush-severed axonal halves seal and thus are available for 
PEG-fusion in vivo.  Recently, we investigated whether compounds that decrease 
plasmalemmal sealing in B104 neurons in vitro, could be used to enhance PEG-fusion 
and promote even greater behavioral recovery in models of peripheral cut- and crush-
severance injury in rats (Bittner et al., 2012).  For example, the anti-oxidant methylene 
blue (MB) has been reported to decrease plasmalemmal sealing in B104 neurons in vitro 
(Spaeth et al., 2012) and slightly improve behavioral recovery following retinal/optical 
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damage (Zhang et al., 2006; Rojas et al., 2009).  Application of MB in Ca
2+
-free 
hypotonic physiological saline to crush- or cut-severed rat sciatic axons, prior to 
application of PEG, dramatically improved PEG-fusion induced behavioral recovery, in 
vivo (Bittner et al., 2012).  These more recent data suggest that insights obtained from 
studies on endogenous sealing mechanisms in B104 neurons in vitro, can have very 
beneficial effects on immediate and long-term PEG-repair of peripheral nerve injury, and 
possibly stroke, in mammals in vivo.  
STROKE: AS MODELED BY OXYGEN-GLUCOSE DEPRIVATION IN VITRO 
To model ischemia (stroke) in vitro, cells are often incubated in an anaerobic (0% 
oxygen) chamber at 37°C in media lacking glucose (0% glucose) (Jones, 2004). Cells are 
then returned to normoxic, normoglycemic conditions – simulating reperfusion.  Such 
OGD exposures increase Ca
2+
 influx, calpain activity, membrane permeability, 
membrane damage and cell death, as observed in tissue explants and models of stroke in 
vivo (Yoshioka, 2000; Cao, 2010). 
It is well documented that ischemia (oxygen glucose deprivation; OGD) produces 
plasmalemmal damage (Rodriguez-Sinovas, 2005).  OGD-induced plasmalemmal 
disruptions are easily observed as membrane blebs, in vitro (Neiminen, 1988).  As an 
ischemic event progresses, the integrity of cell plasmalemmas worsen, blebs form, grow, 
coalesce and eventually burst, releasing cytoplasmic contents and causing cell death.  
Such plasmalemmal damage caused by stroke in humans, results in loss of functional 
behavior and is the third leading cause of death in the USA (Roger, 2011; Janardhan and 
Qureshi, 2004).  However, increasing cells endogenous ability to repair (seal) their 
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damaged plasmalemma can decrease the severity of tissue damage and increase 
functional behavior recovery (Rojas et al., 2009; Nehrt, 2010; Britt, 2010; Bittner et al., 
2012). 
 
SUMMARY OF RESULTS 
The goals of my dissertation research were as follows: 1) determine which PKC 
isozymes and their effectors, and whether DAG and other DAG-activated proteins are 
involved in plasmalemmal sealing (Chapter 2), 2) investigate whether 
inhibiting/enhancing PKC- and PKA-dependent sealing promotes PEG-repair of PNCI in 
a rat model (Chapter 3) and 3) determine what role PKCs may have in sealing of 
ischemia-induced plasmalemmal damage in an in vitro model of stroke in B104 neurons 
(Chapter 4).   
Chapter 2 Summary 
To investigate whether DAG, PKC isozymes, MARCKS, Munc13-1 influence 
sealing, we transected one neurite of individually-identified B104 hippocampal cells, in a 
DAG-analog or inhibitors of PKC, MARCKS, Munc13-1 or phospholipase C (PLC).  We 
assessed plasmalemmal repair by formation of a barrier to extracellular dye (Krause et al. 
1994; Steinhardt et al. 1994; Spaeth et al. 2010).  I report, for the first time a role for 
DAG and DAG-activated proteins in sealing.  Specifically, data show that exogenously 
increasing DAG concentration increased sealing, and decreasing endogenous DAG 
production via PLC or MARCKS inhibition, or inhibition of DAG-activated targets, such 
as nPKC η and θ and Munc-13, but not cPKCs, decreased sealing.  Additionally, 
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simultaneous inhibition of nPKC η, θ and PKA nearly eliminated sealing, suggesting that 
DAG-dependent sealing pathways interact with previously reported cAMP-dependent 
pathways of sealing (Spaeth et al 2010, 2011).  These data and other demonstrate a role 
for DAG-dependent proteins that act in parallel with previously identified cAMP-
dependent proteins during plasmalemmal sealing of B104 and other eukaryotic cells. 
Chapter 3 
I investigated if application of inhibitors of PKC and PKA to crush-severed axons 
in vivo, immediately following crush-severance in physiological calcium concentration, 
could promote PEG-fusion.  We used dye exclusion (as previously described in Chapter 
2) to assess the effect of PKC and PKA inhibitors singly, or in combinations with PEG on 
endogenous sealing in B104 cells in vitro.  We assessed restoration of 
electrophysiological and morphological continuity of crush-severed axons by measuring 
conduction of compound action potentials and dye diffusion across crush-lesion sites in 
vivo and in vitro, respectively (Britt et al., 2010). 
I report that only simultaneous inhibition of nPKC η and θ, and PKI 
(ηPSF+θPSF+PKI) was capable of decreasing plasmalemmal sealing when neurites of 
B104 cells were transected in calcium in vitro.  B104 cells with transected neurites 
always sealed when PEG was applied, even in inhibitors of nPKCs and PKA 
(individually or in combination), and in Ca
2+
-free saline in vitro.  Applying PEG in 
ηPSF+θPSF+PKI proved to be a cytotoxic combination for both intact and damaged 
(neurite transected) B104 cells. 
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All crush-severed sciatic nerves receiving ηPSF+θPSF+PKI treatment to their 





salines, had dye diffuse through their lesion site.  Dye did not diffuse across the lesion 





physiological salines.  As expected, compound action potential conduction was not 





-containing physiological salines in vivo.  PEG application 
restored morphological continuity and electrophysiological conductivity of crush-severed 
sciatic axons only in treatment groups in which the crush was performed in Ca
2+
-free 
hypotonic physiological saline.  Taken together, our B104 cell and sciatic nerve data 
suggest that nearly-complete inhibition of endogenous axonal sealing via 
ηPSF+θPSF+PKI, has no beneficial effect on PEG-fusion, i.e., this treatment does not 
promote PEG-fusion following crush-severance in Ca
2+
-containing saline.  Lastly, these 
data strongly suggest that endogenous axonal sealing is neuroprotective and that acutely 
inhibiting sealing at the time of injury may have long-lasting effects on axonal viability 
and therefore, regeneration after such treatments. 
Chapter 4 
I performed a preliminary study that investigated whether the same PKC 
isozymes involved in sealing transected B104 neurites, also promote sealing of oxygen-
glucose deprivation (OGD)-induced plasmalemmal damage in B104 neurons.  I report 
that, unlike sealing of transected B104 neurites, the presence of Ca
2+
 following 
immediate OGD exposures of 1, 3, 5 or 10 minutes, did not promote sealing probability 
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in B104 cells compared to cells not receiving Ca
2+
 following similar OGD exposures.  
However, cells exposed to peptide inhibitors of nPKC η or θ, during OGD exposures of 
1, 3, 5 or 10 minutes had significantly decreased sealing probability compared to 
normoxic (no treatment) controls and, cells exposed to only OGD.  These data suggest 
that nPKC η and θ promote sealing of OGD-induced plasmalemmal damage in B104 
cells, as they do for sealing of transected neurites of B104 cells. 
 
CONCLUSION 
The data presented here in this dissertation suggest that enhancing PKC-
dependent endogenous sealing following PNCI or stroke, should directly promote neuron 
survival and indirectly, axonal regeneration.  As demonstrated in Chapter 3, near-
complete inhibition of endogenous sealing did not promote PEG-fusion of severed axons 
crushed in physiologically relevant Ca
2+
 concentrations.  Suggesting that following any 
form of neurotrauma, promotion of neuroprotective endogenous sealing should be a 
primary goal because, cells that do not seal, do not survive (McNeil et al., 1993; Nguyen 
et al., 2005), much less regenerate axons. 
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Chapter 2: Sealing of transected neurites of rat B104 cells requires a 
diacylglycerol PKC-dependent pathway and a PKA-dependent pathway 
 
SUMMARY  
 To survive, neurons and other eukaryotic cells must rapidly repair (seal) 
plasmalemmal damage.  Such repair occurs by an accumulation of intracellular vesicles 
at or near the plasmalemmal disruption.  Diacylglycerol (DAG)-dependent and cAMP-
dependent proteins are involved in many vesicle trafficking pathways.  Although recent 
studies have implicated the signaling molecule cAMP in sealing, no study has 
investigated how DAG and DAG-dependent proteins affect sealing.  Using dye exclusion 
to assess Ca
2+
-dependent vesicle-mediated sealing of transected neurites of individually 
identifiable rat hippocampal B104 cells, we now report that, compared to non-treated 
controls, sealing probabilities and rates are increased by DAG and cAMP analogs that 
activate PKC and Munc13-1, and PKA.  Sealing is decreased by inhibiting DAG-
activated novel protein kinase C isozymes η (nPKCη) and θ (nPKCθ) and Munc13-1, the 
PKC effector myristoylated alanine rich PKC substrate (MARCKS) or phospholipase C 
(PLC).  DAG-increased sealing is prevented by inhibiting MARCKS or protein kinase A 
(PKA).  Sealing probability is further decreased by simultaneously inhibiting nPKCη, 
nPKCθ and PKA.  Extracellular Ca
2+
, DAG or cAMP analogs do not affect this decrease 
in sealing.  These and other data suggest that DAG increases sealing through MARCKS 
and that nPKCη, nPKCθ and PKA are all required to seal plasmalemmal damage in 




     Ca
2+
 influx at sites of plasmalemmal damage activates competing pathways, 
one leading to cell death by Ca
2+
-dependent proteases (Schlepfer et al. 1973; Nguyen et 
al. 2005) and the other to vesicle-mediated plasmalemmal repair (sealing) (Krause et al., 
1994;  Steinhardt, et al. 1994; Eddleman, et al. 1998; Detrait et al. 2000a,b; McNeil et al.  
2001; Nguyen et al. 2005).  To survive, all eukaryotic cells (including neurons) must 
rapidly repair (seal) plasmalemmal damage (Fishman and Bittner, 2003; Spaeth et al. 
2010).  Vesicles formed by endocytosis of nearby undamaged membrane (Eddleman et 
al. 1997, 1998), lysosomes (Reddy et al. 2001), and/or myelin delaminations (Ballinger et 
al. 1997) migrate, accumulate, and pack tightly at the damage site to reduce the influx of 
extracellular Ca
2+
 and other ions.  This vesicle-mediated repair of plasmalemmal damage 
is increased by calpain (Godell et al. 1997; Yoo et al. 2003), proteins involved in vesicle 
trafficking and membrane fusion, such as SNAP-25, NSF (Spaeth, et al. 2011), 
synaptobrevin (Yoo, et al. 2003), cAMP effectors PKA and Epac, calpain (Godell et al. 
1997; Yoo et al. 2003) and novel protein kinase C isozyme η (nPKCη) (Spaeth et al. 
2010).  However, little is known about how PKCs and other diacylglycerol (DAG) - 
activated proteins mediate sealing or if DAG-dependent sealing is part of, or parallel to, 
cAMP-dependent sealing pathways (Spaeth et al. 2010, 2012).  
The PKC family is divided into three subgroups based on allosteric activators that 
bind to its regulatory domain (pseudosubstrate region; Larsson, 2006).  The classical 
isozymes (cPKC α, β1, β2, γ) require both calcium and diacylglycerol (DAG), a product 
of phosphatidyl inositol (4,5) bisphosphate (PIP2) hydrolysis by phospholipase C (PLC).  
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Novel isozymes (nPKC δ, ε, η, θ) require only DAG for activation.  Both cPKC and 
nPKC isozymes contain the DAG binding C1 domain (Brose and Rosenmund 2002).  In 
contrast, atypical isozymes (aPKC ι/λ, ζ) require neither calcium nor DAG (Larsson, 
2006).  Active PKC isozymes regulate many vesicle-mediated pathways.  Specifically, 
axonal growth cone turning, transport of beta-1 integrins and neurite extension require 
cPKC and nPKC-dependent phosphorylation of myristoylated alanine rich C kinase 
substrate (MARCKS: Sivasankaran et al. 2004; Gatlin et al. 2006; Siskova et al.2006; 
Tsai et al. 2007). DAG also activates Munc13-1, a vesicle priming protein during 





 independent vesicular fusion events (Basu et al. 2007).  Hence, DAG 
activation of cPKC and nPKC isozymes, MARCKS and/or Munc13-1 might influence 
vesicle-mediated plasmalemmal sealing. 
To investigate whether DAG, PKC isozymes, MARCKS, and/or Munc13-1 
influence sealing, we transected one neurite of individually-identified B104 hippocampal 
cells, in a DAG-analog or inhibitors of PKC, MARCKS, Munc13-1 or phospholipase C 
(PLC).  We assessed plasmalemmal repair by formation of a barrier to extracellular dye 
(Krause et al. 1994; Steinhardt et al. 1994; Spaeth et al. 2010).  We report a role for DAG 
and DAG-activated proteins in sealing.  Specifically, our data show that exogenously 
increasing DAG concentration increased sealing, and decreasing endogenous DAG 
production via inhibition of PLC or MARCKS, or inhibition of DAG-activated targets, 
such as nPKC η and θ and Munc-13, but not cPKCs, decreased sealing.  Additionally, 
simultaneous inhibition of nPKC η, θ and PKA nearly eliminated sealing, suggesting that 
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DAG-dependent sealing pathways interact with previously reported cAMP-dependent 
sealing pathways (Spaeth et al 2010, 2011).  These and other data suggest that DAG-
dependent proteins act in parallel with previously identified cAMP-dependent proteins 
during plasmalemmal sealing of B104 and other eukaryotic cells. 
 
RESULTS 
Experimental conditions for assessing sealing 
The plasmalemma of B104 cells was damaged by transecting a single neurite with 
a glass micropipette (Yoo et al., 2004), always >50μm from the soma in a Petri dish 
containing Ca
2+
-free saline (Spaeth et al., 2010; 2011), fluorescein (green) dye, and when 
applicable, treatment substances.  Typically, 30 – 100 cells were transected per dish for 
each treatment during a 10 min period (see Online Resource 3).  After transection, the 
Ca
2+
-free saline was replaced with Ca
2+
-containing saline (referred to as Ca
2+
 addition) to 
simultaneously induce sealing in all transected cells.  At various times Post-Ca
2+
 addition 
(PC time), a second extracellular dye, Texas red dextran, was added for 10 minutes to the 
Ca
2+
-containing saline.  The Texas red dextran was then removed by rinsing with Ca
2+
-
containing saline.   
Transected cells were uniquely identified by uptake of fluorescein (green) and the 
bisection of a neurite by the score mark made by the micropipette. Plasmalemmal sealing 
was assessed by uptake or exclusion of Texas red dextran from each individually-
identifiable fluorescein-labeled cell (Nguyen et al., 2005).  For example, transected cells 
that did not seal at a given PC time emitted both green and red (fluorescein and Texas red 
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dextran) fluorescence.  Sealing probability was calculated as the percent of cells that 
sealed (i.e. excluded Texas red dextran) divided by the total number of cells damaged per 
condition at any given PC time.  Control sealing data describe cells transected in Ca
2+
-
free saline without any treatment, and then exposed to Ca
2+
-containing saline at various 





p > 0.05) compared to control sealing data in three previous studies (Spaeth et 
al., 2010, 2011a,b) at the same PC times by different researchers performing the same 
protocol.  Hence, we use the same control sealing curve (gray dashed-line) in all figures. 
Because some compounds (Bis I, Gö6976, U73122, U73343) used in this study 
were dissolved in DMSO, as a further control we tested whether DMSO influenced 
plasmalemmal sealing.  DMSO (90 μM) had no effect on rate (p > 0.05, FZT) or 
probability (p > 0.05, CMH χ
2
) of sealing at any PC time compared to control sealing 
(gray dashed line in Fig. 2A and all subsequent figures). 







independence was used to determine statistically significant differences between sealing 
probabilities of treatment versus control sealing or between two treatments (Agresti, 
1996; Yoo et al. 2004; Nguyen et al. 2005; Spaeth et al. 2010, 2011a,b,c). Significant 
differences between treatment versus control sealing or between two treatment groups are 
indicated on graphs with no symbol (p > 0.05) or by asterisks (p ≤ 0.05 by *, p ≤ 0.01 by 




Figure 2: Sealing probability (%) vs. PC time (min): 
(A) Effect of DMSO vehicle (90 μM) on sealing compared to control sealing (gray 
dashed line in this and all other graphs). 
(B) Effect of 100μM OAG (an exogenous DAG analog), 16μM U73122, 16μM U73343 
(inactive analog of U73122), or combination of 16μM U73122+100μM OAG on sealing. 
(C) Effect of 100μM OAG addition, post-transection (Post-OAG addition time), on 
sealing (i.e., cells never exposed to exogenous Ca
2+
). 
(D) Effect of 100 μM OAG or 1mM db-cAMP (analog of cAMP and enhancer of sealing: 
Spaeth et al. 2010) on sealing. 
Significance levels between a treatment and control sealing for this and all other figures 
and tables are indicated by no symbol (asterisk) = p > 0.05, * =, p ≤ 0.05, ** = p ≤ 0.01 
and *** = p ≤ 0.001. 
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B104 cells express PKA, cPKC α, and β1, and nPKC η, and θ 
   As reported previously, PKA is expressed in B104 cells (Spaeth et al. 2011).  To 
examine whether nPKC and cPKC isozymes are expressed in B104 cells, cytosolic 
fractions collected from B104 cells were separated on 4 to 20% SDS PAGE and 
transferred to nitrocellulose membranes that were probed with monoclonal PKCα or 
PKCθ or, polyclonal PKCβ1 or PKCη antibodies. We observed expression of cPKC α and 
β1 and, nPKC η and θ isozymes (Fig. 3). 
 
 
Figure 3: PKC isozyme expression in B104 cells: 
Western blots confirmed expression of cPKCα (77 kDa), cPKCβ1 (80 kDa), nPKCη (82 
kDa), and nPKCθ (85 kDa). Molecular weight marker: Blue Ranger, Pierce (see 
Methods). 
 
The DAG analog OAG increases sealing 
As previously reported, inhibition of nPKCη by 7μM nPKCη pseudosubstrate 
fragment (ηPSF) significantly decreases the rate and probability of sealing at all PC times 
compared to control sealing (Spaeth et al. 2010).  Because nPKC isozymes such as 
nPKCη require DAG for activation, we hypothesized that a DAG analog would increase 
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sealing of transected neurites of B104 cells.  We exogenously added the membrane-
permeable DAG analog 1-Oleoyl-2-acetyl-sn-glycerol (OAG: Doherty et al. 1995; Wang 
and Oram, 2007; Ju et al. 2010), to increase the intracellular DAG concentration.  B104 
cells transected in 100μM OAG sealed at a significantly increased probability at 2.5 and 5 
minutes PC (p ≤ 0.001 and p ≤ 0.01, CMH χ
2
, respectively) and rate of sealing (p ≤ 0.01, 
FZT) compared to control sealing (Fig. 2B; Table 1).  These data suggest that OAG 
increases sealing of B104 cells. 
 
OAG does not substitute for Ca
2+ 
Because OAG treatment enhanced Ca
2+
-dependent sealing, we investigated 
whether OAG could substitute for Ca
2+
 during sealing.  We transected B104 cell neurites 
in Ca
2+
-free saline, and instead of replacing Ca
2+
-free saline with Ca
2+
-containing saline 
following transections, we added Ca
2+
-free saline containing 100μM OAG to transected 
cells.  We assessed dye exclusion at various post-OAG times, instead of PC time (Fig. 
2C, Table 1).  Damaged B104 cells initially sealed at a probability and rate similar to 
control sealing but, exhibited a significant (p ≤ 0.001) decline in sealing probability at 20 
minutes PC compared to control sealing.  The observed decrease in sealing may be due to 
cell death, the breakdown of a previously formed plasmalemmal seal, or both.  These data 
suggest that DAG can initially bypass Ca
2+
 requirements for sealing, but longer-term cell 
viability requires Ca
2+
-dependent processes (Spaeth et al. 2011). 
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Inhibiting PLC decreases sealing  
 Because PLC hydrolyzes PIP2 into DAG (and IP3), we hypothesized that 
inhibition of PLC with 16μM U73122, a potent and specific PLC inhibitor (Bleasdale et 
al. 1990; Hildebrandt et al. 1997; Tanaka et al. 2003) would decrease plasmalemmal 
sealing, possibly by limiting DAG production.  B104 cells transected in 16μM U73122 
sealed at a significantly decreased probability (p ≤ 0.001, CMH χ
2
) at 5, 10 and 20 
minutes PC, but not different rate (p > 0.05, FZT), compared to control sealing (Fig. 2B; 
Table 1).  As an additional control, we transected B104 cells in 16μM U73343, an 
inactive analog of U73122 (Bleasdale et al. 1990; Hildebrandt et al. 1997; Tanaka et al. 
2003) and assessed dye exclusion at various PC times.  Cells transected in U73343 did 
not seal at a significantly different rate (p > 0.05, FZT) or  probability (p > 0.05, CMH χ
2
) 
at any PC time compared to control sealing (Fig. 2B; Table 1).  These results suggest 
that PLC activity promotes sealing of transected neurites of B104 cells. 
 
The DAG analog OAG promotes sealing when PLC is inhibited 
Because the DAG analog OAG enhanced sealing (Fig. 2B), and DAG acts 
downstream from PLC, we hypothesized that OAG would overcome decreased sealing 
due to PLC inhibition.  Cells transected in  U73122+100μM OAG sealed at a 
significantly faster rate (p > 0.05, FZT) and higher probability (p > 0.05, CMH χ
2
) at all 
PC times compared to cells transected in U73122 alone (Fig. 2B).  This observed 
increase in sealing probability and rate was not significantly different from control 
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sealing.   That is, the DAG analog OAG returned sealing to control levels in the presence 
of PLC inhibition, suggesting that DAG promotes sealing downstream of PLC. 
 
Inhibition of cPKC α or β1 does not decrease sealing 
Because plasmalemmal sealing is a Ca
2+
-dependent vesicle-mediated process 
(Krause et al. 1994; Fishman and Bittner, 2003), we hypothesized that inhibition of Ca
2+
-
dependent cPKC α and β1 by adding cPKC PSF 20-28 (Jungnickel et al. 2007) would 
decrease plasmalemmal sealing.  However, B104 cells transected in 8µM PSF20-28 did 
not seal at a significantly different probability (p > 0.05, CMH χ
2
) or rate (p > 0.05, FZT) 
of sealing compared to control sealing (Fig. 4A; Table 1).  These data suggest that 
cPKCs do not influence sealing or that PSF20-28 does not inhibit cPKCs in B104 cells.  
To investigate whether cPKCs influence sealing, we used two small-molecule 
inhibitors of cPKCs, Bisindoylmaleimide I (Bis I) and Gö6976, at concentrations 
reported to affect only cPKCs and decrease sealing in fibroblasts in vitro (Togo et al. 
2004).  B104 cells transected in 1μM Gö6976, 100nM Bis 1, or 1µM Bis 1, did not seal at 
a significantly different probability (p ≥ 0.05, CMH χ
2
) or rate (p > 0.05, FZT) compared 
to control sealing (Fig. 4A; Table 1).  These results suggest that DAG-activated nPKC θ 
and η (Spaeth et al. 2010), but not Ca
2+
-dependent cPKC α or β1, promote sealing of 




Figure 4: Sealing Probability (%) vs. PC time (min): 
(A) Effect of Bis 1 (100nM, 1µM), 1μM Gö6976, or 8μM PSF20-28 on sealing.  
(B) Effect of 7μM ηPSF, 9μM θPSF, or combination of 7μM ηPSF+9μM θPSF on 
sealing.  For additional data on nPKC PSFs, see Online Resources 1 and 2. 
(C) Effect of 100 μM OAG or 1mM db-cAMP in 7μM ηPSF or 9μM θPSF on sealing. 
(D) Effect of 100 μM OAG or1mM db-cAMP in 7μM ηPSF+9μM θPSF on sealing. 
   
 
Inhibition of nPKCη or θ decreases sealing 
Since nPKC isozymes are activated by DAG, and inhibition of nPKCη by 7μM 
nPKCη pseudosubstrate fragment (ηPSF) has been reported to significantly decrease the 
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rate and probability of sealing at all PC times compared to control sealing (Spaeth et al. 
2010), we hypothesized that inhibition of other PKC isozymes would decrease sealing. 
To inhibit PKC isozymes, we used peptide pseudosubstrate fragments (PSFs) that 
bind and inhibit active catalytic domains of PKC. [PSFs typically have increased target 
specificity and reduced off-target effects compared to small-molecule inhibitors (Davies 
et al. 2000; Churchill et al. 2009).]  B104 cells transected in 9μM θPSF (Staal et al. 2008; 
Barros et al. 2009) sealed at a significantly decreased probability (p ≤ 0.001, CMH χ
2
) at 
all PC times, but not rate (p > 0.05, FZT), compared to control sealing (Fig. 4B; Table 
1).  These results suggest that nPKCθ promotes sealing in B104 cells. 
Table 1:  Effect of compounds on sealing rate (k) and time (τ) constants 




> 50 µm τ 
(min) 





at 20 min PC 
Control  0.49 2.03 0.9991 94 
DMSO 0.30 3.30 0.9868 94 
η PSF 0.15     6.58 ** 0.9618 67 
θ PSF 0.41 2.45 0.9975 42 
η PSF+θ PSF   1.17 * 0.85 0.9975 34 
20-28 PSF 0.48 2.09 0.9995 91 
Go6976 0.38 2.66 0.9788 97 
Bis1 100 nM 0.50 2.00 0.9866 96 
Bis1 1 µM 0.26 3.79 0.9962 96 
U73122 0.68 1.48 0.9998 51 
U73343 0.66 1.51 0.9998 89 
OAG    1.46 ** 0.69 0.9999 95 
OAG no Ca
2+
 N/A N/A N/A 17 
U73122+OAG 0.49 2.06 0.9979 93 
MARCKSpi 0.20   5.05 * 0.9993 51 
MARCKSpi+OAG 0.40 2.48 0.9995 67 
NEM 0.29 3.42 0.9989 46 
NEM+OAG 0.44 2.25 0.9970 82 
PKI 0.23 4.35 1.0000 42 
NEM+PKI 0.40 2.49 0.9224 33 
PKI+OAG 0.31 3.21 0.9952 37 
θ PSF+OAG 0.53 1.90 0.9924 96 
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η PSF+OAG 0.94 1.07 0.9908 93 
η PSF+θ PSF+OAG 0.57 1.75 0.9985 42 
db-cAMP 1.22 * 0.82 1.0000 98 
θ PSF+db-cAMP 0.76 1.31 0.9998 53 
η PSF+db-cAMP 0.33 3.06 0.9300 83 
η PSF+θ PSF+db-cAMP 0.35 2.84 1.0000 12 
η PSF+θ PSF+PKI (PBS
2+
) N/A N/A N/A 3 
η PSF+θ PSF+PKI 0.18 5.45 0.9439 2 
η PSF+θ PSF+PKI+OAG (PBS
2+
) N/A N/A N/A 7 
η PSF+θ PSF+PKI+OAG 0.44 2.28 1.0000 3 
η PSF+θ PSF+PKI+db-cAMP (PBS
2+
) N/A N/A N/A 1 
η PSF+θ PSF+PKI+db-cAMP 14.99 *** 0.07 1.0000 1 
Bref-A 0.58 1.73 0.9255 52 
Bref-A+OAG 0.42 2.39 1.0000 97 
Muncpi 4.14 ** 0.74 1.0000 28 
Muncpi+OAG 0.37 2.71 0.9972 94 
Muncpi+db-cAMP 0.35 2.82 0.9933 93 
Muncpi scramble 0.31 3.20 1.0000 92 
Muncpi scramble+OAG 1.82 ** 0.55 1.0000 95 
Muncpi scramble+db-cAMP 1.53 ** 0.65 0.9997 97 
Table 1: Statistical comparisons of sealing rate (k, min
_1
) or exponential time constants 
(τ, min) for transected neurites of B104 cells.  R 
2
 >50μm represents goodness of fit 
values obtained from a single exponential model fitted to sealing probability at all PC 
times for control sealing or a given treatment. 
 
Simultaneous inhibition of nPKC η and θ does not further decrease sealing 
Because 7μM ηPSF or 9μM θPSF (inhibitors of nPKC η and θ, respectively) 
individually decreased, but did not completely eliminate sealing, we hypothesized that 
simultaneous inhibition of nPKCη+nPKCθ, with 7μM ηPSF+9μM θPSF would further 
decrease plasmalemmal sealing compared to either inhibitor alone.  We first confirmed 
that B104 cells transected in 7μM ηPSF sealed at a decreased rate (p > 0.05 FZT) and 
probability (p ≤ 0.001, CMH χ
2
) at all PC times, compared to control sealing (Fig. 4B; 
Table 1), as reported by Spaeth et al (2010). We next observed that B104 cells transected 




probability at 2.5, 5 and 20 minutes PC and significantly (p ≤ 0.05, FZT) increased rate 
compared to control sealing (Fig. 4B; Table 1).  However, cells transected in 7μM 
ηPSF+9μM θPSF sealed at a significantly (p ≤ 0.001, CMH χ
2
) decreased probability at 
20 minutes PC compared to cells transected in 7μM ηPSF, but not other PC times (Fig. 
4B). Furthermore, cells transected in 7μM ηPSF+9μM θPSF sealed at a significantly 
(p≤0.05, FZT) faster rate of sealing compared to cells transected in either 7μM ηPSF or 
9μM θPSF (Table 1).  That is, sealing was not further decreased by simultaneous 
inhibition of nPKC η and θ compared to either inhibitor acting alone, suggesting that 
nPKC η and θ likely target the same substances in sealing pathways. 
 
nPKC η and/or θ  act downstream of DAG 
Since DAG-dependent sealing requires nPKC η and θ, we hypothesized that the 
decrease in sealing due to inhibition of nPKCs singly, or in combination, would not be 
affected by addition of OAG if nPKC η and/or θ act downstream of DAG.  B104 cells 
transected in ηPSF+100μM OAG or, 9μM θPSF+100μM OAG did not seal at a 
significantly different rate (p > 0.05, FZT) or probability (p > 0.05 CMH χ
2
) at any PC 
time compared to control sealing (Fig. 4C; Table 1).  B104 cells transected in 7μM 
ηPSF+9μM θPSF+100μM OAG sealed at a significantly decreased probability (p > 0.05 
CMH χ
2
), but not rate (p > 0.05, FZT) at all PC times compared to control sealing (Fig. 
4D; Table 1).  Furthermore, 7μM ηPSF+9μM θPSF+100μM OAG had no effect on rate 
(p > 0.05, FZT) or probability (p > 0.05 CMH χ
2
) of sealing compared to 7μM 
ηPSF+9μM θPSF (compare open circles, Fig. 4B to filled circles, Fig. 4D).  These data 
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suggest that nPKC η and θ act downstream to DAG in the DAG-dependent sealing 
pathway. 
 
Inhibition of other DAG-dependent proteins decrease sealing  
Inhibition of MARCKS decreases sealing 
In neurons, cPKC- and nPKC-dependent phosphorylation of MARCKS increases 
PIP2 availability for hydrolysis by PLC, thus increasing DAG concentration (Laux et al. 
2000).   Therefore, we hypothesized that inhibiting MARCKS with 100μM MARCKS 
peptide inhibitor (MARCKSpi; Agrawal et al. 2007), would decrease plasmalemmal 
sealing.  B104 cells transected in 100μM MARCKSpi sealed at a significantly decreased 
probability (p ≤ 0.001, CMH χ
2
) at 2.5, 5 and 20 minutes PC, but not rate (p > 0.05, 
FZT), compared to control sealing (Fig. 5A; Table 1).  These data suggest that 
MARCKS promotes sealing of transected B104 cells and acts upstream of DAG.  
Inhibition of Munc13-1 decreases sealing 
Munc13-1, a synaptic fusion protein (Basu et al. 2007), requires DAG for 
activation (Brose and Rosenmund, 2002).  Because a DAG analog and DAG-activated 
nPKC η and θ promote plasmalemmal sealing (Figs. 2B, 4B), we hypothesized that 
inhibiting Munc13-1 with a peptide (Mochida et al. 1998; referred to as, Muncpi) would 
decrease plasmalemmal sealing.  B104 cells transected in 10 µM Muncpi sealed at a 
significantly decreased probability at 2.5, 5, and 20 minutes PC (p ≤ 0.001, CMH χ
2
), but 
not rate of sealing (p > 0.05, FZT), compared to control sealing (Fig. 5B; Table 1). 
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Figure 5: Sealing Probability (%) vs. 
PC time (min): 
(A) Effect of 100μM MARCKSpi; 
100μM MARCKSpi+100μM OAG on 
sealing. 
(B) Effect of 10μM Muncpi, 10μM 
Muncpi+100μM OAG, 10μM 
Muncpi+1mM db-cAMP on sealing.  
(C) Effect of 10μM Muncpi scramble, 
10μM Muncpi scramble+100μM 
OAG, 10μM Muncpi scramble+1mM 
















As a control for non-specific effects of Muncpi, we transected B104 cell neurites 
in 10 µM Muncpi with amino acids in a different order (termed “Muncpi scramble”) 
(Mochida et al. 1998), and assessed dye exclusion at various PC times.  B104 cells 
transected in 10 µM Muncpi scramble did not seal at a significantly different rate (p > 
0.05, FZT) orprobability (p > 0.05, CMH χ
2
) compared to control sealing (Fig. 5C; Table 
1).  These data suggest that Munc13-1 promotes sealing of transected B104 cells. 
 
OAG only partially reverses inhibition of MARCKS 
We hypothesized that MARCKS acts upstream of DAG during plasmalemmal 
sealing, and thus increasing DAG would only partly overcome the effects of MARCKS 
inhibition.  To test this hypothesis, we transected cells in 100μM MARCKSpi+100μM 
OAG.  These cells sealed at a significantly increased probability at 2.5, 5 and 20 minutes 
PC (p ≤ 0.001, p ≤ 0.001 and p ≤ 0.05 CMH χ
2
), but not rate (p > 0.05, FZT), compared 
to 100μM MARCKSpi alone (Fig. 5A; Table 1).  However, B104 cells transected in 
100μM MARCKSpi+100μM OAG sealed at a significantly decreased probability at 2.5, 
5 and 20 minutes PC (p ≤ 0.01, p ≤ 0.001, and p ≤ 0.05 CMH χ
2
), but not rate (p > 0.05, 
FZT), compared to control sealing (Fig. 5A; Table 1).  These data demonstrate that OAG 
cannot restore sealing to control levels when MARCKS is inhibited, suggesting that 
MARCKS acts upstream of DAG. 
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OAG restores sealing to control levels when Munc-13 is inhibited  
 Since Munc13-1 is one of many redundant fusion proteins used for DAG-
dependent plasmalemmal sealing, we hypothesized that exogenously increasing DAG 
would increase sealing to control levels when Munc-13 is inhibited by 10 µM Muncpi.  
We observed no significant difference in rate (p > 0.05, FZT) or probability (p > 0.05, 
CMH χ
2
) of sealing at any PC time compared to control sealing when B104 cells were 
transected in 10 µM Muncpi+100μM OAG (Fig. 5B).  An experimental control, we 
transected B104 cells transected in 10 µM Muncpi scramble+100μM OAG and observed 
that they had a significantly increased rate (p ≤ 0.01, FZT) and probability of sealing at 
2.5 and 5 min PC (p ≤ 0.001, p ≤ 0.01 CMH χ
2
) compared to control sealing.  These data 
suggest that Munc13-1 acts downstream of DAG and is one of many membrane-fusion 
proteins, such as syntaxin, SNAP-25, synaptobrevin, used by DAG-PKC-dependent 
sealing pathways to form a plasmalemmal seal (Spaeth et al. 2010, 2011). 
OAG does not overcome inhibition of PKA 
Inhibition of PKA by 50μM PKI decreases sealing in B104 cells (Spaeth, et al. 
2010) and inhibiting DAG decreases sealing (Figs. 2B, 5A).  To determine if PKA- and 
DAG-dependent sealing pathways are independent, we investigated if exogenously 
increasing DAG concentration could overcome PKI inhibition and return sealing to 
control levels. We first confirmed that B104 cells transected in 50μM PKI sealed at a 
significantly decreased probability (p ≤ 0.001, CMH χ
2
) at all PC times, but not rate (p > 
0.05 FZT) of sealing, compared to control sealing (Fig. 6A; Table 1), as previously 
reported (Spaeth, et al. 2010),  We then determined that B104 cells transected in 50μM 
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PKI+100μM OAG  also sealed at a significantly decreased probability (p ≤ 0.001, CMH 
χ
2
) at all PC times, but not rate (p > 0.05 FZT), compared to control sealing (Fig. 6A; 
Table 1).  However, cells transected in  50μM PKI+100μM OAG (open triangles in Fig. 
6A) did not seal at a significantly different probability (p > 0.05, CMH χ
2
) at any PC 
time, or rate or rate (p > 0.05 FZT) compared to cells transected only  in 50μM PKI (Fig. 
6A, open circles).  These data suggest PKA acts downstream to DAG-PKC-dependent 
effects on sealing. 
 
cAMP-dependent sealing is not independent of nPKC-dependent sealing 
Another second messenger, cAMP, in addition to Ca
2+
, also increases sealing of 
transected B104 neurites (Spaeth et al. 2010, 2011a,b)  We hypothesized that db-cAMP, a 
cAMP analog, would increase plasmalemmal sealing to control levels in the presence of 
inhibition  of nPKC.  As an experimental control,  we transected B104 cells in 1mM db-
cAMP, and observed that they sealed at a significantly increased probability (p ≤ 0.001, 
CMH χ
2
) at 2.5 and 5 min PC, and rate (p ≤ 0.05 FZT) compared to control sealing (Fig. 
2D; Table 1). [These data correlate well with previously published data on the effects of 





Figure 6: Sealing Probability (%) vs. PC time (min):  
(A) Effect of 50μM PKI, 100μM OAG in 50μM PKI or, 7μM ηPSF +9μM θPSF+ 50μM 
PKI on sealing.   
(B) Effect of 100μM OAG or 1mM db-cAMP in 7μM ηPSF + 9μM θPSF + 50μM PKI 
on sealing. 
(C) Effect of performing transections in Ca
2+
-containing saline in 7μM ηPSF + 9μM 
θPSF + 50μM PKI, 7μM ηPSF + 9μM θPSF + 50μM PKI +100μM OAG or 7μM ηPSF + 
9μM θPSF + 50μM PKI + 1mM db-cAMP on sealing.  






However,  B104 cells transected in 7μM ηPSF+1mM db-cAMP sealed at a 
significantly decreased probability (p ≤ 0.001, CMH χ
2
) at 2.5 min PC, but at any other 
point compared to control sealing.; the  rate of sealing was no significantly different  (p > 
0.05 FZT) compared to control sealing (Fig. 4C; Table 1).  B104 cells transected in 9μM 
θPSF+1mM db-cAMP sealed at a significantly decreased probability at 2.5, 5 and 20 min 
PC (p ≤ 0.01, p ≤ 0.001, p ≤ 0.001 CMH χ
2
, respectively) but, not rate (p > 0.05 FZT), 
compared to control sealing (Fig. 4C; Table 1).   B104 cells transected in 7μM 
ηPSF+9μM θPSF+1mM db-cAMP had dramatically decreased (p ≤ 0.001, CMH χ
2
) 
sealing probability (≤ 12%) at all PC times, but not rate (p > 0.05 FZT) of sealing, 
compared to control sealing (Fig. 4D; Table 1).  Furthermore, 7μM ηPSF+9μM 
θPSF+1mM db-cAMP dramatically decreased (p ≤ 0.001, CMH χ
2
) sealing probability at 
all PC times compared to 7μM ηPSF+9μM θPSF (compare open circles Fig. 4B to filled 
diamonds Fig. 4D).  These data suggest that cAMP and nPKC affect at least some of the 
same pathways, i.e. cAMP-dependent sealing is not independent of nPKC-dependent 
sealing.  
 
db-cAMP promotes sealing to control levels when Munc-13 is inhibited 
If Munc13-1 is only one of many redundant fusion proteins used for 
plasmalemmal sealing, we hypothesized that exogenously increasing cAMP would 
increase sealing to control levels if Munch 13-1 were inhibited by 10 µM Muncpi.  B104 
cells transected in 10 µM Muncpi+1mM db-cAMP had no difference in rate (p > 0.05, 
FZT) or probability (p > 0.05, CMH χ
2
) of sealing at any PC time compared to control 
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sealing (Fig. 5B).  For experimental controls, we performed the same protocols in 10 µM 
Muncpi scramble, instead of 10 µM Muncpi.  B104 cells transected in 10 µM Muncpi 
scramble+1mM db-cAMP sealed at a significantly increased rate (p ≤ 0.01, FZT) and 
probability of sealing at 2.5 and 5 min PC (p ≤ 0.001, p ≤ 0.01 CMH χ
2
) compared to 
control sealing.  These data suggest that Munc13-1 is one of many membrane-fusion 
proteins, such as syntaxin, or SNAP-25, used by cAMP-PKA-dependent sealing 
pathways to form a plasmalemmal seal (Spaeth et al. 2010, 2011). 
 
Sealing requires nPKC η and θ, and PKA    
Sealing persists following inhibition of nPKC η and/or θ (Fig. 4A) or PKA (Fig. 
6A), providing additional evidence that sealing is promoted by redundant, parallel 
pathways, as previously suggested (Spaeth et al. 2010, 2011).  To examine the possibility 
that DAG-PKC and PKA sealing pathways are redundant, we investigated if sealing 
would be further inhibited when simultaneously inhibiting both pathways compared to 
inhibiting only one.  B104 cells transected in 7μM ηPSF+9μM θPSF+50μM PKI to 
inhibit both pathways sealed at a dramatically decreased (p ≤ 0.001, CMH χ
2
) probability 
(≤ 2%) at all PC times, but not rate (p > 0.05 FZT), compared to control sealing (Fig. 6A; 
Table 1). As a control, we verified that 7μM ηPSF+9μM θPSF+50μM PKI had no 
cytotoxic effects on intact, non-transected cells, i.e., intact cells did not include dye or 
show signs of membrane blebbing (data not shown). These data suggest that sealing 
requires nPKC η and θ, and PKA.    
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To further investigate whether sealing requires nPKC η and θ, and PKA., we 
examined whether enhancers of sealing, OAG or db-cAMP (Fig. 2B, D), could promote 
sealing when nPKCη and θ and PKA were simultaneously inhibited to inhibit both 
pathways.  B104 cells transected in 7μM ηPSF+9μM θPSF+50μM PKI+100μM OAG or, 
7μM ηPSF+9μM θPSF+50μM PKI+1mM db-cAMP sealed at a dramatically decreased (p 
≤ 0.001, CMH χ
2
) probability (≤ 5%) at all PC times compared to control sealing.  
Furthermore, B104 cells transected in 7μM ηPSF+9μM θPSF+50μM PKI+1mM db-
cAMP sealed at a dramatically increased rate (p ≤ 0.001 FZT) compared to control 
sealing (Fig. 6B; Table 1).  B104 cells transected in 7μM ηPSF+9μM θPSF+50μM 
PKI+100μM OAG sealed at a rate (p > 0.05 FZT) not significantly different from control 
sealing (Fig. 6B; Table 1). 
Because 7μM ηPSF+9μM θPSF+50μM PKI decreased sealing so dramatically, 
even in OAG or db-cAMP, we hypothesized that 7μM ηPSF+9μM θPSF+50μM PKI 





) and 100μM OAG or 1mM db-cAMP.  Figure 5C shows that sealing was 
immediately induced when B104 cells were transected in Ca
2+
-containing saline.  B104 
cells transected in and PBS
2+
 containing either 7μM ηPSF, 9μM θPSF, 7μM ηPSF+9μM 
θPSF, or 50μM PKI did not seal at a significantly different probability at 5 min PC 
compared to control sealing (see Online Resource 4). However,  B104 cells transected in 
PBS
2+
 containing 7μM ηPSF+9μM θPSF+50μM PKI or,100μM OAG or 1mM db-cAMP, 
sealed at a  significantly decreased (p ≤ 0.001, CMH χ
2
) probability (≤ 7%) at all PC 
times compared to control sealing (Fig. 6C; Table 1).  Taken together, these data are 
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consistent with the hypothesis that nPKC η and θ and PKA are all normally required for 
sealing of B104 cells  
 
OAG restores sealing to control levels when Golgi trafficking is inhibited 
Inhibition of Golgi trafficking with Brefeldin A (Bref A) decreases plasmalemmal 
sealing in fibroblasts (Togo et al. 2003), rabbit epithelial corneal cells (Shen and 
Steinhardt, 2005) and B104 cells (Spaeth et al. 2011).  Such decreased sealing can be 
partially overcome by activation of PKA (Spaeth et al. 2011).  We hypothesized that 
inhibiting Golgi traffic would also inhibit PKC-DAG-dependent plasmalemmal sealing. 
That is, decreased sealing produced by Bref A inhibition of Golgi trafficking could be 
reversed by increased DAG concentrations.  We first confirmed (Spaeth et al. 2010) that 
B104 cells transected in 10μM Bref-A  to reduce Golgi trafficking had significantly 
decreased sealing probability (p ≤ 0.001, CMH χ
2
) at all PC times, but not rate (p > 0.05, 
FZT) of sealing, compared to control sealing (Fig. 7A, Table 1). In contrast,  B104 cells 
transected in 10μM Bref-A+100μM OAG did not seal at a significantly different rate (p > 
0.05, FZT) or probability (p > 0.05, CMH χ
2
) at all PC times compared to control sealing 





Figure 7: Sealing Probability (%) vs. PC time (min):  
(A) Effect of 10μM Bref-A or 10μM Bref-A + 100μM OAG on sealing. 
(B) Effect of 1mM NEM or 1mM NEM + 100μM OAG on sealing. 
 
OAG restores sealing to control levels in presence of NSF inhibition   
 Because NSF inhibition cannot be overcome by cAMP-dependent activation of 
PKA, we reason that NSF is downstream of PKA activated substances (Spaeth et al. 
2011).  We hypothesized that PKC-DAG-dependent sealing would also require NSF 
similar to cAMP-dependent sealing, and therefore increased DAG concentration would 
not restore sealing when NSF was inhibited by NEM.  We transected neurites in 1mM 
NEM (NSF inhibitor: Rodriguez et al. 1994) or, 1mM NEM+100μM OAG.  B104 cells 
transected in 1mM NEM sealed at a significantly decreased probability (p ≤ 0.001, CMH 
χ
2
) at all PC times, but not rate (p > 0.05, FZT) of sealing, compared to control sealing 
(Fig. 7B, Table 1).  In contrast,  B104 cells transected in 1mM NEM+100μM OAG had 
no difference in rate (p > 0.05, FZT) or probability (p > 0.05, CMH χ
2
) of sealing at any 
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PC time compared to control sealing(Fig. 7B, Table 1). These data suggest that DAG, 
unlike cAMP, acts downstream of NSF. 
DISCUSSION    
Summary of Results 
 Our present and previously reported data from B104 cells and data from many 
other eukaryotic preparations (see Supplementary Reference list in Spaeth et al. 2010) 
suggest that vesicle-mediated plasmalemmal sealing in eukaryotic cells, is an 
evolutionarily conserved process.  This sealing is induced by Ca
2+
 influx at 
plasmalemmal damage sites (Fishman and Bittner, 2003) and enhanced by increased 
cAMP concentration (Spaeth et al. 2010) and DAG concentration and utilizes multiple 
vesicle-mediated pathways and membrane sources (Ballinger et al. 1997; Eddleman et al. 





-independent membrane fusion proteins, such as synaptobrevin, 
syntaxin, synaptophisin, synaptotagmin (Steinhardt et al. 1994; Detrait et al. 2000a,b; 
Yoo et al. 2003), Munc13-1 and, enzymes, such as PKA (Spaeth et al. 2010), nPKC η 
and θ for formation and maintenance of a plasmalemmal seal (Fig. 8A, B). 
In this study we transected neurites of B104 cells in the presence of specific 
peptide inhibitors of PKC isozymes PKA, MARCKS and Munc13-1 and small-molecule 
inhibitors of PKC, PLC, NSF and Golgi trafficking --sometimes in the presence of 
analogs of DAG or cAMP.   Our data suggest that DAG increases sealing by activating 
MARCKS, and Munc 13-1, and that nPKCη, nPKCθ and PKA are all required to seal 
plasmalemmal damage (Fig. 8). 
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nPKCθ promotes sealing 
B104 cells express cPKC α and β1 and, nPKC η and θ isozymes (Fig. 3).  DAG-
activated nPKCθ, but not Ca
2+
-activated cPKC isozymes, promotes plasmalemmal 
sealing of transected neurites (Fig. 4A, B).  Our data also suggest that nPKCθ-dependent 
mechanisms influence sealing more than nPKCη-dependent mechanisms (Spaeth et al., 
2010). For example: 1) nPKCθ inhibition alone, cause a greater decrease in sealing 
compared to nPKCη inhibition (Fig. 4B), (2) combining nPKC θ and η inhibitors further 
decreases sealing compared to nPKCη inhibition alone, at 20 min PC, (Fig. 4B) and (3) 
combining nPKC θ and η inhibitors does not further decrease sealing compared to 
nPKCθ inhibition alone (Fig. 4B).   
   
Endogenous DAG production is important for sealing 
  DAG is produced when PLC hydrolyzes PIP2.  PLC is typically activated by G-
protein coupled receptors but can also be activated by Ca
2+
-induced calpain cleavage 
(Glass et al. 2002; Ray et al. 2003; Fig. 8A).  Our data show that exogenously adding the 
membrane permeant DAG analog OAG (Ju et al. 2010) increases sealing probability and 
rate in a Ca
2+
-dependent manner, but DAG cannot substitute for Ca
2+
 (Fig. 2B, C).  
Conversely, decreasing endogenous DAG production with the PLC inhibitor U73122 
(Tanaka et al. 2003) decreases sealing probability (Fig. 2B).  These data are consistent 
with previous reports that many vesicle-mediated processes such as axonal growth cone 
turning, transport of beta-1 integrins and neurite extension (Gatlin et al. 2006; 
Sivasankaran et al. 2004; Gatlin et al. 2006; Siskova et al. 2006; Tsai et al. 2007) require 
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MARCKS is required for an increase in sealing produced by DAG 
Previous studies suggest that nPKC-dependent phosphorylation of MARCKS 
unmasks PIP2 micro-domains, making PIP2 available for hydrolysis by PLC (Frey et al. 
2000; Laux et al. 2000). We observe that inhibition of MARCKS by a peptide-specific 
inhibitor (that blocks PKC phosphorylation site) significantly decreases sealing, even in 
exogenously increased DAG concentration (Fig. 5A).  These data suggest that 
MARCKS-PIP2 micro-domains are a crucial source of DAG that may promote and 
reinforce DAG-dependent plasmalemmal sealing in a feed-back loop.  DAG production 
at a site of plasmalemmal damage might activate nPKC, which then phosphorylates 
MARCKS, freeing more PIP2 for PLC-dependent hydrolysis.  Increased PIP2 would then 
increase intracellular [DAG], thereby further activating nPKC or other DAG-activated 
proteins, like Munc13-1 (Fig. 8A). 
Previous studies also suggest that PKC-dependent phosphorylation of MARCKS 
increases DAG concentration along plasmalemmal leaflets, acting as a chemoattractant to 
direct DAG-activated proteins, such as PKC isozymes and PKC-associated vesicle traffic 
(Frey et al. 2000; Laux et al. 2000) to sites of increased DAG concentration.  Hence, 
increased DAG concentration caused by PKC-dependent phosphorylation of MARCKS 
might direct PKC-dependent vesicles, such as those required for axonal growth cone 
turning, transport of beta-1 Integrins and neurite extension (Frey et al. 2000; Laux et al. 
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2000; Kolkova et al. 2000; Gatlin et al. 2006; Siskova et al. 2006; Sivasankaran et al. 
2004; Tsai et al. 2007) to plasmalemmal damage sites in B104 cells via DAG-
chemoattraction of nPKC isozymes (Fig. 8B). 
 
DAG-activated fusion protein, Munc13-1, promotes sealing in B104 cells (Fig. 5B, C) 
Inhibition of Munc13-1 decreases sealing.that can be overcome by exogenously 
increasing DAG or cAMP concentration (Fig. 5B).  These data suggest that Munc13-1 
promotes sealing in B104 cells, and that DAG-PKC and cAMP-PKA sealing pathways 





–independent membrane fusion events (Basu et al. 2007).  Thus, DAG could 
influence the initial formation of a plasmalemmal seal by activating fusion proteins such 
as Munc13-1 to promote vesicle-vesicle, vesicle-membrane interactions as [Ca
2+
] 
increases at the site of plasmalemmal damage and those vesicle interactions could also 
help maintain the seal.  Munc13-1 could also promote sealing through Doc2α binding 
region interactions with SNAREs, such as syntaxin (Mochida et al. 1998). 
 
nPKCη, nPKCθ and PKA are all required for sealing (Figs. 4C-E; 6A-C) 
Previously published data show that sealing is promoted by a cAMP-PKA 
dependent pathway (Spaeth et al. 2010). Our data show that exogenously increasing 
cAMP concentration increases sealing that can be decreased by inhibitors of nPKCη (Fig. 
4C), but not nPKCθ (Fig. 4C) or nPKCη+nPKCθ (Fig. 4D).  Sealing probability is 
further decreased (compared to nPKCη+nPKCθ) by exogenously increasing cAMP 
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concentration, as in PKCη+nPKCθ (Fig. 4D). Together, these data (Fig. 4C, D) suggest 
that DAG-PKC and cAMP-PKA sealing pathways may interact in a feedback loop.  That 
is, a decrease in nPKC in increased cAMP has negative feedback on PKA-dependent 
sealing pathways (Fig. 8A, B).  This negative feedback loop would decrease the activity 
of sealing pathways not blocked by nPKC inhibitors, such as PKA, and would further 
decrease sealing compared to ηPSF+θPSF alone (compare open circles Fig. 4B to filled 
diamonds Fig. 4D).  
Exogenously increasing DAG concentration in nPKCη+nPKCθ (Fig. 4D) or PKA 
(Fig. 6A) inhibition does not increase sealing.  Furthermore, simultaneous inhibition of 
nPKCη, nPKCθ and PKA greatly reduces sealing probability to ≤7% at all PC times (Fig. 
6A), even when cells are transected in Ca
2+
 (to induce sealing immediately after neurite 
transection) and the sealing enhancers OAG or db-cAMP (Spaeth et al. 2010) (Fig. 6B, 
C). Taken together, these data (Fig. 6A-C) strongly suggest that sealing in B104 cells 
requires nPKCη, nPKCθ and PKA.  These data (Fig. 6A-C) suggest that the combination 
of ηPSF+θPSF+PKI very likely limits nearly all pathways of sealing, such as endocytosis 
and trafficking of vesicles to the damage site, and that the remaining sealing pathways are 
DAG and cAMP independent.    
 
DAG-dependent sealing influenced by Golgi-derived vesicle traffic, but not NSF  
Exogenously increasing DAG concentration promotes sealing to control, but not 
OAG-enhanced levels in the presence of Brefeldin-A (Fig. 7A), a potent inhibitor of 
Golgi-derived vesicle traffic.  These data suggest that, like cAMP-PKA dependent 
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sealing (Spaeth et al. 2010, 2011), DAG-dependent sealing is enhanced by Golgi-
dependent traffic, and that OAG can partially overcome inhibitory effects of Brefeldin A 
by recruiting vesicles from nPKC- and MARCKS-dependent sources.  Alternatively, 
OAG may also increase the ability of a more limited supply of vesicles to fuse, thereby 
enhancing sealing in Bref A.  Since Brefeldin A may also inhibit activity of the cAMP 
activated guanine exchange factor Epac (Spaeth et al. 2011), these data also suggest that 
sealing initiated by DAG does not strongly depend on Epac. 
Exogenously increasing DAG concentration promotes sealing to control levels in 
the presence of NEM (Fig. 7B), a potent inhibitor of NSF.  These data suggest that, 
unlike cAMP-PKA dependent sealing (Spaeth et al. 2010, 2011), DAG-PKC dependent 
sealing is not greatly influenced by NSF and that components of DAG-PKC dependent 
sealing work downstream of NSF.  For example, these data suggest that DAG-activated 
fusion proteins, such as Munc13-1, which primes vesicles and is involved in membrane 





Figure 8: Plasmalemmal sealing, an evolutionarily conserved process: 
(A) Flow chart of Ca
2+
 induced plasmalemmal sealing including PLC, nPKCs, 
MARCKS, DAG and Munc13-1, cAMP, PKA and membrane-fusion proteins that have 
been shown to promote sealing. 
(B) Model of Ca
2+
 induced plasmalemmal sealing including PLC, nPKCs, MARCKS, 
DAG and Munc13-1 (See in References: Steinhardt et al. 1994; Godell et al. 1997; 
Detrait et al. 2000a,b; McNeil and Terasaki, 2001; Shen and Steinhardt, 2005; Togo et al. 
2003, 2004, 2006; Spaeth et al. 2010). 
 
SIGNIFICANCE 
In this study, we describe what percentage of cells seal at a given PC time (sealing 
probability) and how quickly (sealing rate) the population of transected cells progresses 
to a maximum sealing probability for a given treatment.  The high R
2
 Goodness of Fit 
values in Table 1 suggest that various treatments can affect both probability and rate of 
sealing.  Our data are consistent with many mechanisms that could affect rate and 
probability of sealing, e.g. substrate limitation or allosteric changes in proteins.  
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Our data show that PKCs and DAG influence plasmalemmal sealing in neurons in 
vitro.  Such insights have direct and indirect implications for axonal regeneration after 
traumatic injury (Bozkurt 2008; Bittner et al, 2012) and for stroke in which neuronal 
membranes are damaged (Rodriguez-Sinovas et al. 2005).  For example, cells that do not 
seal plasmalemmal damage, do not survive (Nguyen et al. 2005).  Therefore, compounds 
that enhance endogenous sealing (OAG or db-cAMP) may be capable of rapidly 
promoting sealing of neurons damaged by traumatic injury or stroke, thereby greatly 
diminishing loss of behavioral function correlated with neurotrauma and stroke.  As a 
second example, compounds that inhibit endogenous sealing (nPKC or PKA peptide 
inhibitors) may be capable of enhancing polyethylene glycol (PEG) induced fusion of 
plasmalemmas, thereby greatly increasing the already profound effects of PEG on 
recovery of physiological and behavioral functions of crushed and/or severed peripheral 
nerves (Bittner et al. 2012).  Thus, a greater knowledge of proteins and substrates that 
influence plasmalemmal repair (sealing) in vitro, should provide targets and substrates to 
improve neuroprotective treatment modalities. 
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MATERIALS AND METHODS  
B104 cells: 
B104 cells derived from a CNS neuroblastoma (Bottenstein and Sato, 1979) have often 
been used as a model system to study neuronal function in vitro (Yoo et al. 2003; Nguyen 
et al. 2005; Miller et al. 2006; Spaeth et al. 2010). B104 cells extend neurites that have 
properties typical of nerve axons such as generation of action potentials, smooth (but not 
rough) endoplasmic reticulum, release of neurotransmitter, and regeneration of severed 
neurites. These cells have easily identifiable cell bodies and neurites, allowing precise 
identification of individually transected cells at their injury site (Detrait et al. 2000b; Yoo 
et al. 2003, 2004; Spaeth et al. 2010). Unlike some other model neuronal cell lines (e.g., 
PC12 cells), B104 cells do not require growth factor supplements of fetal bovine serum to 
proliferate (Detrait et al. 2000b; Yoo et al. 2003; Spaeth et al. 2010). Data on sealing of 
B104 cells are consistent with similar data on sealing from at least 20 other preparations 




As described previously (Nguyen et al. 2005; Spaeth et al. 2010), B104 cells were grown 
in 75 cm
2
 vented cap flasks (BD Falcon; BD Biosciences) in a humidified incubator at 
37°C in 5% CO2 and in 4 ml of cell growth medium: consisting of a 1:1 mixture of 
Dulbecco’s modified Eagle’s medium and Ham’s F12 (DMEM:F-12, HyClone) 
supplemented for growth with 10% heat-inactivated fetal bovine serum (FBS; HyClone) 
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and 1% antibiotics (10,000 U of penicillin/ml and 10 mg/ml streptomycin; Sigma-
Aldrich). The cell growth medium was changed every 2 d. Cultures were passaged at 
80% confluency, and cells were then either subcultured in a vented cap flask or seeded at 
~2000 cells/cm 
2
 in cell growth media on Petri dishes coated with poly-D-lysine (Sigma-
Aldrich) to prevent cells from detaching during solution changes and/or neurite 
transection.  After 24 h, the growth media was replaced with serum-free DMEM:F12 
(Hyclone) to allow the B104 cells to differentiate. B104 neurites were transected 24–48 h 
after replacing the cell growth media with serum-free DMEM:F12. 
 
Transection of neurites of B104 cells: 
Before transecting neurites, the solution (DMEM:F12) in the Petri dish was washed out 
twice with a Ca
2+
-free phosphate-buffered saline (referred to as “Ca
2+
-free saline,” PBS=; 
HyClone).   All neurites were transected in Ca
2+ 
-free saline at a distance >50 μm from 
the soma using a sharpened, pulled glass, microcapillary tube (“micro-knife”) that was 
placed on a micromanipulator (Narishige Instruments) and quickly drawn across the 
surface of the Petri dish, etching a score line that showed the path of the micro-knife. In 
all experiments, 3 kDa fluorescein dextran (Invitrogen) was added to the Ca
2+
-free saline 
during transection of B104 cell neurites to label cells transected by the microknife.  As 
described previously (Yoo et al. 2004), only B104 cells with transected neurites uptake 
fluorescein dye, therefore we were able to uniquely and individually identify each B104 
cell with a transected neurite by fluorescein dextran fluorescence and the relation of the 
transected cell/neurite to the score mark on the plate.  
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Microscopic observations of dye exclusion: 
For all experiments, B104 cells were observed under an inverted Zeiss ICM-405 
fluorescent microscope with a 40X long focal distance lens.  Cells with neurites 
obviously transected >50 μm from the soma were observed for fluorescein dextran uptake 
and Texas Red dextran in/exclusion. No further observations were made on  transected 
cells that did not uptake fluorescein dextran. 
 
Assessment of plasmalemmal sealing: 
As described previously (Spaeth et al. 2010), we used the most reliable measure of 
plasmalemmal repair (dye exclusion) to assay plasmalemmal sealing (Blanchette et al. 
1999; Detrait et al. 2000a,b).  To assess plasmalemmal repair, we first transected 10–130 
cells in Ca
2+
-free saline containing fluorescein dye within 10 min.  The Ca
2+
-free saline 







; HyClone) to initiate the sealing process (Detrait et al. 2000b; Yoo et al. 2003; 
Spaeth et al. 2010).  The time elapsed after exposing cells to Ca
2+
-saline is defined as the 
“post- Ca
2+ 
addition time” (PC time). Thus, all cells on a given Petri dish have the same 
PC time.  At various PC times (0–20 min PC), 3 kDa Texas Red dextran (Invitrogen) was 
added to the Ca
2+
-saline.  After a 10 min exposure, Texas Red dextran was thoroughly 
washed out with Ca
2+
-saline, and then sealing was assessed.  Transected cells (damaged 
neurite, green fluorescence) that excluded Texas Red dextran were counted as “sealed”.  
Cells that did not exclude Texas Red dextran were counted as “not sealed”. Nearby 
undamaged cells never took up Texas Red dextran.  As stated previously (Spaeth et al. 
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2010), we consistently used 3 kDa Texas Red dextran to assess sealing in all experiments 
to decrease variability in dye exclusion assessments because, fluorescent dyes of higher 
molecular weight are excluded faster than lower molecular weight dyes (Detrait et al. 
2000a; Yoo et al. 2003), which are excluded faster than ions having even lower molecular 
weights than the smallest dye (Krause et al. 1994; Eddleman et al. 2000).  
 
Pharmacological reagents: 
We used pharmacological agents to quickly inhibit or activate a target protein to avoid 
complications of compensatory pathways that may result from gene knock-outs or 
chronic applications of pharmacological inhibitors (Steinberg et al. 2008). All 
pharmacological reagents were typically dissolved in Ca
2+
-free saline and added to cells 
immediately before neurites were transected to backload cells with each reagent during 
transection. The following isozyme specific peptide inhibitors of PKC were purchased 
from EMD Chemicals, Gibbstown, NJ: myristoylated cPKC pseudosubstrate fragment 
20-28 (8μM, 1.2 kDa) to inhibit cPKCα/β1 (Liu et al. 2006; Jungnickel et al. 2007; Ratz 
and Miner, 2009), myristoylated nPKCη pseudosubstrate fragment (7 μM, 2 kDa) was 
used to inhibit nPKCη (Liu et al. 2006; Barros et al. 2009; Spaeth et al. 2010), 
myristoylated nPKCθ pseudosubstrate fragment (9 μM, 2.3 kDa) to inhibit nPKCθ (Staal 
et al. 2008; Barros et al. 2009).  Bisindoylmaleimide I (100nM, 1μM and 10μM, 0.4 kDa; 
Sigma Aldrich) and Gö6976 (1μM, 0.3 kDa; Sigma Aldrich) were used to inhibit cPKC 
isozymes (Togo, 2004). We used U73122 (16 μM, 0.4 kDa; Sigma Aldrich) to inhibit 
phospholipase C (PLC) activity and for a negative control, we used the inactive analog of 
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U73122, U73343 (16 μM, 0.4 kDa; Sigma Aldrich) (Bleasdale et al. 1990; Hildebrandt et 
al. 1997; Tanaka et al. 2003). To increase diacylglycerol (DAG) activity, we exogenously 
applied the DAG analog, 1-Oleoyl-2-acetyl-sn-glycerol (100 µM; Cayman Chemicals, 
Ann Arbor, MI), referred to as OAG (Doherty et al. 1995; Wang and Oram, 2007; Ju et 
al. 2009). We used Mid-peptide (10 µM, 2.9 kDa, Genscript, Piscataway, NJ) to inhibit 
Munc13-1 and scrambled Mid-peptide (10 µM, 2.9 kDa) as a control (Mochida et al. 
1998).  We used BIOMARCKS-11006 peptide inhibitor (100 µM; a gracious gift from 
Dr. Indu Parikh of BioMARCKS Pharmaceuticals, Durham, NC) to inhibit MARCKS 
(Agrawal et al. 2007; Damera et al. 2010). PKI (50 μM, 1.8 kDa; Sigma-Aldrich; a 
generous gift from Drs. Michael Markham and Harold Zakon, University of Texas, 
Austin, TX) was used to specifically inhibit PKA (Spaeth et al. 2010). Dibutyryl-cAMP 
(db-cAMP, 1 mM, 0.4 kDa; Sigma-Aldrich) was used to increase intracellular cAMP 
activity.  We used N-ethylmaleimide (NEM, 1mM; Thermoscientific, Rockford, IL) to 
inhibit NSF (Rodriguez et al. 1994) and Brefeldin-A (Bref-A, 10 µM; Biomol/Enzo 
Lifesciences, Farmingdale, NY) to inhibit Golgi-derived vesicle traffic (Togo et al. 2003; 
Shen and Steinhardt, 2005). 
 
Western Blotting: 
As described previously (Spaeth et al. 2010), once cells in vented cap flasks reached 80% 
confluency, they were removed from the surface of the flask using 1% Trypsin (Sigma), 
and collected in a pellet by gentle (4000 rpm) centrifugation.  The pellet was re-
suspended in 500 µL M-Per mammalian protein extraction buffer (Fisher).  A broad 
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protease cocktail inhibitor was added to prevent protein degradation (Fisher).  Cells were 
gently shaken on a rotating table at 4˚ C for 30 minutes, and then vortexed for 1-2 
minutes.  Samples were denatured using Running Buffer/Lane marker (Fisher) and run on 
4% stacking, 20% separating gels (Promega).  Proteins were electro-transferred onto 
nitrocellulose membranes (Fisher).  The membranes were pre-blotted with 5% BSA 
(Fisher) and probed with monoclonal PKCα or PKCθ or, polyclonal PKCβ1 or PKCη 
primary antibodies (SantaCruz Biotechnologies). (AbCam).  The blots were washed in 
TBST (0.1% Tween 20 in TBS) and incubated in goat anti-rabbit IgG-HRP at a dilution 
of 1:10,000.  The blots were washed and developed with Super Signal (Pierce).  Blue 
Ranger (Pierce) molecular weight standard was run on every gel in lanes 1 and 10. 
 
Statistical analyses: 
As described previously (Spaeth, 2010), we obtained data from individual, uniquely 
identified B104 cells that all received similar, well-specified, neurite transections as 
plasmalemmal injuries in a tightly controlled environment. For each treatment group, at a 
given PC time the data were pooled for all cells (n) from all Petri dishes (N).  See 
Appendix Table B, for n and N values for each data set at each PC time point in all 
figures presented in this paper.  “Sealing probability” is defined as the percentage of a set 
of individually-transected and uniquely identified cells that exclude 3 kDa Texas Red dye 
(sealed) at a given PC time. As described previously (Detrait et al. 2000b; Yoo et al. 




) test for 
independence was used as the most appropriate statistical test to determine whether 
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differences between sealing probabilities at a given PC time for different experimental 
treatments were statistically significant (p<0.05). Briefly, the CMH χ
2 
test for 
independence is used to compare data separated into two-by-two contingency tables 
(sealed or not sealed, and control vs. experimental data sets). Furthermore, the CMH χ
2 
test requires binary outputs, which applies to our sealing assay (sealing is treated as a yes 
or no event at a given PC time). Because sealing of a given cell and not each Petri dish 
(sometimes containing over 100 transected cells) are independent events, measures of 
variance (such as SE or SD) are not applicable. 
GraphPad Prism4 was used to curve-fit a one-phase exponential equation (Equation 1 
below) to sealing probability data  at all PC times for a given control or treatment (dashed 
and solid lines on all graphs, respectively) to obtain a “sealing rate”.  Sealing rate is the 
time it takes for a population of transected cells to reach the sealing maximum for a given 
treatment.  
y(t) = Ymax * (1 – e
-kt
),   (Equation 1) 
Equation 1: y(t) is the sealing probability (%) of cells examined at a given PC time (t), 
Ymax is the maximum plateau sealing probability (%) of cells for that control or treatment 
, e is Euler’s constant, t is a given PC time (min), and k is the rate constant (min
-1
) of a 
given exponential equation.  The rate constant k is the reciprocal of the time constant (τ, 
min) defined as the elapsed PC time needed to achieve 63.2% (reciprocal of Euler’s 
constant) of the observed maximum (plateau) sealing.  The time constants were 
calculated according to Eq. 1 where τ = 1/k. The maximum sealing probability (plateau) 
was always reached within 20 min PC.  Sealing time constants or rate constants for 
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controls and treatments were normalized and compared by using Fisher’s Z 
transformation (FZT). Two sealing constants were considered significantly different if p 
was < 0.05, using a Z table. Goodness of fit (R
2
) values were obtained from GraphPad 
Prism4 to determine how closely the exponential equations modeled the observed data 
(see Table 1). 
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Chapter 3: Application of nPKC and PKA inhibitors to crush-severed 
sciatic axons, immediately following crush in physiological calcium 
concentration, do not increase probability of PEG-fusion (immediate 
axonal repair)  
 
INTRODUCTION 
One of the most common traumatic peripheral nerve injuries in humans is 
peripheral nerve crush injury (Fig. 9).  Typically caused by compression (Fig. 9C) of 
surrounding tissues upon the nerve, that sometimes completely severs axons (Fig. 9D) 
within the nerve, resulting in significant behavioral deficits (Campbell, 2008).  Severed 
distal axonal segments in mammals undergo Wallerian degeneration within 1-3 days 
post-injury, compounding loss of functional behaviors.  Recovery of functional behavior 
for denervated target tissues is a function of axonal regeneration.  Outgrowths from 
surviving proximal axonal stumps (Fig. 9D) grow at 1-2mm/day, often only partially and 
non-specifically re-innervating distal target tissues.  At this  slow regeneration rate, it can 
take weeks-to-years before regenerating motor axons reach denervated and usually, 
atrophied, target tissues in large mammals, post-operatively (Ramon y Cajal, 1928; 
Bozkurt et al. 2008; Campbell, 2008; Lago et al. 2007; Kalbermatten et al. 2009). 
Improving the rate and extent of mammalian axonal regeneration has been a 
major research goal for many neuroscientists. All repair strategies to date, including 
nerve grafts, nerve growth guides, and microsutures, have relied upon axonal outgrowths 
to re-innervate target tissues. Such techniques have improved the number and specificity 
of regenerating axons slightly, but never the time course of behavioral recovery (Lago et 
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al. 2007; Kalbermatten et al. 2009).  Likewise, it has failed to prevent Wallerian 
degeneration of severed distal axons (Lore et al. 1999; Marzullo et al. 2002; Stavisky et 
al. 2005; Britt et al. 2010).  
Following plasmalemmal damage, mammalian axons that fail to seal do not 
survive (Schlaepfer and Bunge, 1973; Detrait et al. 2000; Yoo et al. 2003; Nguyen et al. 
2005).  That is, sealing of plasmalemmal damage can be neuroprotective.  Plasmalemmal 
sealing of small holes, as well as complete axonal transections in mammalian neurons 
and other eukaryotic cells is normally produced by a Ca
2+
-induced accumulation of 
membrane-bound structures (mostly vesicles).  These vesicles accumulate at damage 
sites, fusing to each other and nearby undamaged plasmalemma, by various protein 
isomers, many of which are Ca
2+
-dependent and involved in membrane fusion at 
synapses or the Golgi apparatus, to seal the damage site (see Chapter 2, Introduction on 




Figure 9: Simplified schematic of peripheral nerve crush injury. 
(A) Cross section of sciatic nerve (peripheral nerve of leg in humans) showing general 
anatomy of nerve. 
(B) Sagittal (lengthwise) section of sciatic nerve, simplifying axonal paths as perfectly 
parallel within fascicles. 
(C) Depiction of force compressing external epineurium upon sciatic axons, crush-
severing axons. 
(D) Result of such a compression force is complete crush-severance of sciatic axons 
resulting in loss of axonal continuity, loss of conduction of action potentials and loss of 
functional behavior in target tissues.   
 
In contrast to the slow and incomplete restoration of functional behavior of 
severed mammalian axons, many invertebrates demonstrate complete restoration of 
behavioral function within days after axonal severance.  This is promoted by fusion of 
proximal outgrowths with surviving distal stumps or activation of distal stumps by 
closely apposed proximal outgrowths (Hoy et al. 1967; Bittner et al. 2000; Bittner and 
Fishman, 2000).  Severed mammalian axons can be repaired within 1-2 minutes 
following injury using the membrane fusogen, polyethylene glycol (PEG) (Krause et al. 
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1991; Stavisky et al. 2005; Britt et al. 2010; Bittner et al. 2012).  Indeed, polyethylene 
glycol (PEG) has been used since the 1970s by cell biologists to fuse various cell types 
and to make cell hybrids (Ahkong, 1987).  PEG is an amphipathic molecule able to 
remove waters of hydration from membrane-bound proteins allowing adjacent lipid 
membranes to flow into one another and is thus used for rapid and permanent in vivo 
repair of severed peripheral nerves in mammals (Britt et al. 2010; Bittner et al. 2012). 
Previous studies reported successful PEG-fusion of axons, especially those using 
mammalian nerve preparations, obtained by bathing the lesion site in hypotonic, Ca
2+
-
free physiological saline prior to PEG application (Fig. 10B).  This is performed to 
reduce or blow out accumulations of vesicles directed to sites of axolemmal disruption 
and transection via Ca
2+
-induced vesicle-mediated repair (Fig. 10A, B; Bittner et al. 
2012; also see Chapter 2 for details on vesicle-mediated repair/sealing).  Such leads to the 
hypothesis that, by reducing vesicle-mediated repair prior to PEG application, more 
closely apposed, severed axonal ends are rendered available for PEG-fusion, increasing 
the number of PEG-fused axons compared to application of PEG to already sealed or 
nearly-sealed axonal ends (Fig. 10).  Following PEG application, isotonic, Ca
2+
-
containing physiological saline is applied to the lesion site to induce endogenous sealing 
mechanisms to “plug” any remaining disruptions in axolemmas (Fig. 10D).  Such PEG-
induced fusions restored morphological continuity and conduction of action potentials 
through the lesion site of invertebrate and vertebrate (rat) axons in vitro and in vivo 
(Krause, 1991; Marzullo, 2002; Stavisky, 2005).  Application of PEG to crush-severed 
sciatic axons significantly increased the rate of functional behavior recovery in crush 
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injury animals that received PEG versus crush injury animals that received vehicle 
treatment in vivo (Britt et al. 2010). 
 




Hypothesized effects of each solution used in sequence to produce PEG-fusion of crush-
severed axons. Crush-severance completely disrupts the axolemma and the endoneurial 
sheath (ENS) at the lesion site, but leaves the epineurial sheath (EPS) intact, ensuring that 
crush-severed ends remain in close apposition. MEL: melatonin, MB: methylene blue, 
PEG: polyethylene glycol. Concentrations: 2mM MEL, 100µM MB, 500mM 2kDa PEG 
(Stavisky et al. 2005, Britt et al. 2010; Spaeth et al. 2011b; Bittner et al. 2012). 
 
Recently, we began to test whether or not compounds that retard in vitro 
plasmalemmal sealing in B104 cells, can be used to enhance PEG-fusion (using the 
protocol in Figure 3.2) and to promote greater behavioral recovery in models of 
peripheral nerve cut- and crush-severance injury in rats (Bittner et al. 2012).  The 
antioxidant methylene blue (MB) has been reported to decrease plasmalemmal sealing in 
B104 cells in vitro (Spaeth et al. 2012) and to improve behavioral recovery slightly 
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following optical (retinal) trauma (Zhang et al. 2006; Rojas et al. 2009).   MB application 
in Ca
2+
-free hypotonic physiological saline to crush- or cut-severed rat sciatic axons, 
prior to application of PEG, dramatically improved PEG-fusion induced behavioral 
recovery, in vivo (Fig. 10B; Bittner et al. 2012).    
The aforementioned treatments (PEG and MB+PEG) produced restoration of 
morphological continuity, electrophysiological conduction, and behavioral function 
following crush- or cut-severance of invertebrate and vertebrate axons when axonal 
damage was performed in hypotonic, Ca
2+
-free physiological saline in vitro, ex vivo and 
in vivo.  However, it has yet to be tested whether any treatment in conjunction with PEG 
is capable of increasing the probability of PEG-fusion following crush-severance in 
physiological calcium concentration, as occurs to human neurotrauma patients, whose 
tissues and interstitial fluids are neither hypotonic nor void of calcium at time of injury. 
Thus, we hypothesize that application of compounds or combinations of 
compounds that greatly reduce plasmalemmal sealing in B104 cells in vitro (such as, 
ηPSF+θPSF+PKI from Chapter 2) to crush-severed axons in vivo, should be capable of 
increasing the probability of PEG-fusion following crush-severance in physiological 
calcium concentration.  Dye exclusion (as previously described in Chapter 2) was used to 
assess the effect of combinations of compounds and PEG on endogenous sealing in B104 
cells in vitro.  We studied restoration of electrophysiological and morphological 
continuity of crush-severed axons by measuring conduction of compound action 
potentials and dye diffusion across crush-lesion sites in vivo and in vitro, respectively 
(Britt et al. 2010). 
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In this chapter, I report that only the inhibitor combination of ηPSF+θPSF+PKI 
was capable of decreasing plasmalemmal sealing of B104 cells transected in calcium in 
vitro.  One-minute PEG application always sealed transected B104 cells, even in 
inhibitors of nPKCs and PKA (individually or in combination) or in Ca
2+
-free saline in 
vitro.  However, ηPSF+θPSF+PKI+PEG treatment proved to be cytotoxic for both intact 
and damaged (neurite transected) B104 cells.   
As predicted, PEG application restored morphological continuity and electro-
physiological conductivity to crush-severed sciatic axons only in treatment groups in 
which the crush was performed in Ca
2+
-free hypotonic physiological saline.  Dye diffused 
throughout crush-severed sciatic nerves receiving ηPSF+θPSF+PKI (with or without 
PEG) treatment at the crush-lesion site, subsequent to crush-severance in Ca
2+
-containing 
physiological saline.  Suggesting such treatment was capable of inhibiting endogenous 
sealing in crush-severed sciatic axons in vivo.  However, no treatment was capable of 
increasing the probability of PEG-fusion of sciatic axons crush-severed in Ca
2+
-
containing physiological saline in vivo.  The weight of our B104 cell and sciatic nerve 
data suggest that nearly-complete inhibition of endogenous axonal sealing via 
ηPSF+θPSF+PKI does not increase the probability of PEG-fusion of sciatic axons crush-
severed in Ca
2+
-containing physiological saline in vivo.  Moreover, these data strongly 
suggest that endogenous axonal sealing is neuroprotective and that almost completely 
inhibiting sealing at the time of injury may have long-lasting negative effects on axonal 




Effect of inhibitors of nPKC and PKA on sealing of transected B104 cell neurites in 
vitro  
To determine if application of PKC and PKA inhibitors following crush in 
physiological Ca
2+
  increases the probability of in vivo PEG-fusion of crush-severed 
sciatic axons, we first determined the effects of these compounds, sometimes in 





-containing (1mM) saline, in vitro.  Neurites of individually identifiable 
B104 cells were transected >50 µM from their soma in Petri dishes in vitro (see Methods 
and Spaeth et al. 2012).  (see Methods). Sealing probabilities, defined in Methods as the 
percent of B104 cells that excluded 3kDa Texas Red dextran for different treatments 
were compared using a Cochran-Mantel-Haenszel χ
2
 test (CMH χ
2
) (Spaeth et al. 2010, 
2012). [We used 10mM PEG for all B104 cell in vitro experiments because this 
concentration was previously determined as the lowest effective concentration that 
provided maximal PEG-sealing (Spaeth et al. 2012).] 
 




For experimental controls we demonstrated, again, that inhibition of nPKC η or θ, 
or PKA decreases endogenous plasmalemmal sealing of transected B104 cells (Fig. 
11A).  B104 cells transected in 7μM nPKCη pseudosubstrate fragment (ηPSF), 9μM 
θPSF, 7μM ηPSF+9μM θPSF, 50μM PKI, 7μM ηPSF+9μM θPSF+50μM PKI sealed at a 
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significantly (p≤0.001) decreased sealing probability at 5 min PC compared to control 
sealing (Fig. 11A).   
To determine if these compounds immediately inhibit sealing, we repeated the 
above experiments with the exception that we transected neurites of individually 
identifiable B104 cells in Ca
2+
-containing saline (to i induce immediate sealing following 





 and either 7μM ηPSF, 9μM θPSF, 7μM ηPSF+9μM θPSF or 50μM PKI sealed at 
a significantly (p≤0.001, CMH χ
2





-containing control sealing (Fig. 11B).  B104 cells transected in Ca
2+
 and 
7μM ηPSF+9μM θPSF+50μM PKI sealed at a significantly (p≤0.001, CMH χ
2
) decreased 




-containing control sealing (Fig. 11B).  
These data suggest that simultaneous inhibition alone of nPKC η and θ and PKA 
decreases endogenous sealing when B104 cell neurites are transected in calcium. 
 
In combination with PEG, simultaneous inhibition of nPKC η, θ and PKA is cytotoxic 
to B104 cells in vitro 
In order to determine if inhibitors of nPKC η, θ and PKA could increase the 
probability of PEG-fusion following crush in calcium in vivo, we investigated if 
inhibition of nPKC η, θ and PKA had any effect on PEG-induced sealing of B104 cell 
neurites transected in Ca
2+
-containing saline, in vitro.  First, we noted the effect of PEG 
alone on endogenous plasmalemmal sealing by transecting B104 cell neurites in Ca
2+
-
free saline in 10mM PEG and assessed sealing at 5 min PC.  To mimic our in vivo PEG-
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fusion protocol, 10mM PEG was applied to cells for only one minute, i.e. PEG was 
applied to cells in the last minute of transection (Spaeth et al. 2012).  B104 cells 
transected in 10mM PEG sealed with a significantly (p≤0.001, CMH χ
2
) increased sealing 
probability compared to Ca
2+
-free control sealing (Fig. 11A, C). 
We next investigated the effect of nPKC and PKA inhibitors on PEG-induced 
sealing.  B104 cells transected in 7μM ηPSF, 9μM θPSF, 7μM ηPSF+9μM θPSF, 50μM 
PKI and 10mM PEG sealed at a significantly (p≤0.001, CMH χ
2
) increased sealing 
probability compared to Ca
2+
-free control sealing (Fig. 11C).  Unexpectedly, all B104 
cells (intact and damaged) exposed to 7μM ηPSF+9μM θPSF+50μM PKI and 10mM 
PEG included dye.  These data suggest that nPKC and PKA inhibitors do not inhibit 
PEG-sealing in Ca
2+
-free saline.  However, nearly-complete inhibition of endogenous 
sealing with 7μM ηPSF+9μM θPSF+50μM PKI in combination with PEG proved to be 
cytotoxic. 
We then assayed the effect of Ca
2+
 and, nPKC and PKA inhibitors on PEG-
induced sealing by transecting B104 cell neurites in Ca
2+
-containing saline and the 
presence of such inhibitors, followed by one minute exposure to 10mM PEG (Fig. 11D).  
B104 cells damaged in Ca
2+ 
and the presence of 7μM ηPSF, 9μM θPSF, 7μM ηPSF+9μM 
θPSF, 50μM PKI and 10mM PEG had significantly (p≤0.001, CMH χ
2
) increased sealing 
probability compared to Ca
2+
-free, but not Ca
2+
-containing control sealing (Fig. 11D).  
Again, all B104 cells (intact or damaged) exposed to 7μM ηPSF+9μM θPSF+50μM PKI 
and 10mM PEG included dye (Fig. 11D). 
All transection data (Fig. 11C, D) suggest the following, to wit:  
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1. PEG can rapidly seal (PEG-seal) plasmalemmal damage in Ca2+-free saline, 
and does not require endogenous sealing mechanisms (nPKC η, θ or PKA) to 
do so (Fig. 11C). 
2.  PEG application does not enhance endogenous sealing of neurites transected 
in Ca
2+
-containing saline (compare Ca
2+
-containing control to PEG in Fig. 
11B, D) 
3. Most importantly, simultaneous inhibition of nPKCs and PKA in conjunction 
with PEG is cytotoxic to intact and transected cells in Ca
2+
-free and –
containing salines (Fig. 11B, D).  These last data (Fig. 11B, D) suggest that 
such treatment (nPKC+PKA inhibitors + PEG) to crush-severed sciatic axons 







Figure 11: Sealing Probability vs. PC time (5 min) 
B104 cells transected in the presence of compounds in Ca
2+
-free (A, C) or Ca
2+
-
containing (B, D) saline for 10 minutes, rinsed with and then exposed to fresh (compound 
free) Ca
2+
-containing saline for 5 minutes.  Texas red dye (3kDa) was added at 5 minutes 
PC. Note, 10mM PEG was applied for only one minute (i.e. the final minute) of 10 
minute transection period (Spaeth et al. 2012). Statistical significance (CMH χ2) 
indicated as asterisks on graph: ***, p≤0.001. See Table 4 in Methods for number of Petri 
dishes used and cells observed in panels A-D. 
(A) Effect of 10mM PEG, 7μM ηPSF, 9μM θPSF, 7μM ηPSF+9μM θPSF, 50μM PKI or 
7μM ηPSF+9μM θPSF+50μM PKI on sealing. Ca
2+
-free Control sealing (no treatment): 
white column in this and all other panels.  
(B) Effect of 10mM PEG, 7μM ηPSF, 9μM θPSF, 7μM ηPSF+9μM θPSF, 50μM PKI or 




(C) Effect of 7μM ηPSF, 9μM θPSF, 7μM ηPSF+9μM θPSF, 50μM PKI or 7μM 
ηPSF+9μM θPSF+50μM PKI on PEG-induced sealing.. 
(D) Effect of Ca
2+
, 7μM ηPSF, 9μM θPSF, 7μM ηPSF+9μM θPSF, 50μM PKI or 7μM 
ηPSF+9μM θPSF+50μM PKI on PEG-induced sealing. 
 
Effect of inhibitors of nPKC and PKA applied to crush-severed sciatic axons in vivo  
 We have recently demonstrated that application of methylene blue (MB), an 
inhibitor of sealing in B104 cells (Spaeth et al. 2012), to crush- and cut-severed rat sciatic 
axons prior to PEG treatment (MB+PEG) significantly improved behavioral recovery 
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from 72 hrs through 3 weeks post-operation, in vivo, compared to PEG treatment only 
(Bittner et al. 2012).  As previously mentioned in the introduction, such successful 
treatments (PEG alone or MB+PEG) depend upon bathing the nerve in Ca
2+
-free 
physiological saline before cut- or crush-severance injury, then in hypotonic Ca
2+
-free 
physiological saline immediately after injury and during administration of treatments in 
vivo (Fig. 10; Britt et al. 2010; Bittner et al. 2012).  Here, we test whether application of 
inhibitors of nPKCs and PKA (recall these inhibitors decrease sealing in B104 cells, like 
MB) prior to PEG application can increase the probability of PEG-fusion following 
crush-severance in calcium, in vivo.   
First, we assessed if such treatments could restore electrophysiological continuity 
as assessed by measurements of compound action potential (CAP) conduction across the 
crush (lesion) site in vivo.  Second, we assessed restoration of morphological 
(cytoplasmic) continuity by fluorescence microscopy assessments of intra-axonal 
diffusion of Texas Red dye through the lesion site in vitro (Britt et al. 2010; Bittner et al. 
2012; Spaeth et al. 2012).  [For details on surgical procedures, electrophysiological 
recordings of CAPs and dye diffusion apparatus, see Methods.] 
 
Application of inhibitors of nPKC η, θ and PKA to crush-severed sciatic axons 
immediately following crush in physiological Ca
2+
 environment did not increase 
probability of PEG-fusion as assessed by CAP conduction across the lesion site 
 Because simultaneously inhibiting nPKC η, θ and PKA dramatically decreased 
sealing in B104 cells transected in calcium (Fig. 11A, B), we hypothesized that such 
treatment applied to crush-severed sciatic axons immediately following a crush injury in 
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calcium could increase the probability of PEG-fusion, and restore electrophysiological 
continuity, in vivo. 
To assess if application of inhibitors of nPKC η, θ and PKA, prior to PEG, could 
restore electrophysiological continuity of crush-severed axons crushed in calcium, we 
extracellularly stimulated and recorded the ability of sciatic axons to conduct CAPs in 
vivo.  We used two pairs of hook electrodes, one pair to stimulate and the other to record 
CAPs on an oscilloscope (Britt et al. 2010).  All crush-severance lesions were made 
between the two electrodes, abolishing CAP conduction (Crush CAP data not shown).  
Tables 2, 3 give CAP amplitude data recorded in vivo from crush-severed sciatic nerves 
before (Initial CAP) crush-severance, after PEG application (PEG-fusion CAP), and 
percent restoration of initial CAPs by PEG-fusion.  Following CAP recordings, nerves 




Figure 12: Assessment of CAP conduction through uncrushed (initial), 
crushed and PEG-fused sciatic axons 
A: Crush in hypotonic, Ca
2+
-free physiological saline: CAP conductivity was restored 
only after PEG treatment. 
B:  Crush in isotonic, Ca
2+
-containing physiological saline:  CAP conductivity was not 
restored by PEG or any other treatment. 
 
CAPs were always detected in all intact sciatic nerves and never detected across 
the lesion site immediately after crushing the sciatic nerve (for n values, see Tables 2, 3). 
CAPs were only detected post-crush only for Sham (no crush or treatment), and all 
Crush+PEG treatment groups, in which crush, and PEG application were performed in 
Ca
2+
-free and hypotonic, Ca
2+
-free physiological salines respectively (Fig. 12A, Table 
2).  No treatment (with or without PEG) was capable of restoring CAP conductivity 
following crush in Ca
2+
-containing physiological saline; not even Methylene blue (MB) 
in addition to ηPSF (Fig. 12B, Table 3). 
We statistically analyzed CAP amplitudes using One-Way ANOVA with Tukey’s 





treatment groups were not statistically different (p > 0.05) compared to their respective 
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Shams (Tables 2, 3).  PEG-fusion CAPs (Table 2) from treatment groups including 
nPKC and/or PKA inhibitors and PEG were not statistically (p > 0.05) different 
compared to Crush+PEG alone (Table 2).  Lastly, there was no statistical (p > 0.05) 
difference in CAP amplitude between Initial and PEG-fusion CAPs for any treatment 
with successful PEG-fusion (Table 2).  Together, these electrophysiological data suggest 
that inhibitors of nPKC and PKA are not capable of promoting PEG-fusion of crush-
severed sciatic axons crushed in physiological calcium concentration. 
 
Application of inhibitors of nPKC η, θ and PKA to crush-severed sciatic axons 
immediately following crush in physiological Ca
2+
 environment did not increase 
probability of PEG-fusion as assessed by dye diffusion across the lesion site 
To assess if application of inhibitors of nPKC η, θ and PKA, prior to PEG, could 
restore morphological continuity of crush-severed sciatic axons crushed in calcium, we 
assessed diffusion of Texas red dye (3 kDa) through crush lesion sites in vitro, using 
conventional fluorescence microscopy. We excised 3-4 cm lengths (with lesion site 
roughly in middle of excised segment) of sciatic nerve from rats previously used in our in 
vivo assessments of electrophysiological continuity.  The most proximal excised end was 
placed in a watertight Vaseline well containing dye (Texas Red dextran) dissolved in 
Ca
2+
-free saline (see Dye diffusion in Methods). The lesion site was outside the well and 
maintained in Ca
2+
-containing isotonic saline.  
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Figure 13: Dye diffusion through a representative PEG-fused crush-severed nerve 
A, B: Light (A) and fluorescence (B) images of a crush-severed rat sciatic nerve, crushed 
in hypotonic, Ca
2+
-free physiological saline.  Dashed line indicates crush lesion site in A 
and B. Proximal portion of nerve left of crush lesion, distal portion of nerve right of 
lesion. (B) Dye diffused through lesion site. Scale bar 100 μm at 10x magnification.  For 
additional dye diffusion images in rat sciatic nerves see, Spaeth et al. 2012.   
 
Dye always diffused (Fig. 13) through the lesion site for Sham (no crush or 
treatment), and all Crush+PEG treatment groups, in which crush, and PEG application 
were performed in Ca
2+
-free and hypotonic, Ca
2+
-free physiological salines respectively 
(Table 2).  Dye also diffused through the lesion site of Crush+7μM ηPSF+9μM 
θPSF+50μM PKI treated nerves. This group did not receive PEG, but dye did diffuse 
through the lesion site (Table 2).  Dye never diffused through the lesion site of  Ca
2+
-
containing crush treatment groups, except for sham-operated (no crush or treatment), 
crush+7μM ηPSF+9μM θPSF+50μM PKI and crush+7μM ηPSF+9μM θPSF+50μM 
PKI+PEG (note for the latter two treatments, nor was CAP conduction restored, even 
with PEG application) (Table 3). 
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These dye diffusion data suggest that no treatment (nPKC or PKA inhibitors and 
PEG), following crush-severance in Ca
2+
-containing saline, is capable of restoring 
morphological continuity of crush-severed axons.  As expected, dye diffused through the 
lesion site of all PEG-fused nerves (i.e. crush-severance and PEG application was 
performed in Ca
2+
-free and hypotonic, Ca
2+
-free saline respectively).  These PEG-fusion 
data correlate with our previously published results on restoration of morphological 
continuity to those crush-severed axons, that received crush-severance injury and PEG 
application in Ca
2+
-free and hypotonic, Ca
2+
-free saline respectively (Britt et al. 2010; 
Bittner et al. 2012).  Moreover, these dye diffusion data suggest that simultaneous 
application of inhibitors of nPKCη, θ and PKA can decrease sealing in severed axons, 
even those crush-severed in calcium, as evidenced by dye diffusion through the lesion 
site of Crush+7μM ηPSF+9μM θPSF+50μM PKI treated nerves; whether or not calcium 
was present during crush or, PEG was applied to the lesion site (Tables 2, 3). 
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Sham 3 1.7±0.4 n/a n/a 100 Yes 
Crush 5 2.0±0.3 n/a n/a 100 No 
Crush+PEG 2 1.8±0.6 Yes 1.3±0.1 72 Yes 
Crush+ηPSF+θPSF+PKI 4 3.4±0.3 n/a n/a n/a Yes 
Crush+PKI+PEG 2 2.7±1.0 Yes 1.4±0.3 52 Yes 
Crush+ηPSF+PEG 6 1.8±0.3 Yes 2.0±0.3 111 Yes 
Crush+ηPSF+MB+PEG 6 2.3±0.4 Yes 2.0±0.2 87 Yes 
Crush+θPSF+PEG 2 1.5±0.2 Yes 1.1±0.5 73 Yes 
Crush+ηPSF+θPSF+PEG 2 2.2±0.2 Yes 1.3±0.1 59 Yes 
Crush+ηPSF+θPSF+PKI+PEG 4 2.5±0.3 Yes 1.8±0.6 72 Yes 
 
Table 2: CAP and dye diffusion data for treatment groups in which crush was performed 
Ca
2+
-free saline and subsequently bathed in hypotonic Ca
2+
-free physiological saline. 
Immediately following crush injury, inhibitors of nPKCs or PKA (dissolved in hypotonic 
Ca
2+
-free physiological saline) were applied to crush site. (Sham group: no crush, no 
treatment) 
 
Tables 2 and 3: 
CAPs: Prior to injury, CAP conduction was assessed in intact nerves (Initial).  Crush-
severance was determined as complete when CAP conduction was abolished, i.e., CAP = 
0mV.  Hence, “crush” CAPs are not indicated in table for any treatment group.  
Immediately following crush injury, inhibitors of nPKCs or PKA (dissolved in hypotonic 
Ca
2+
-free physiological saline) were applied to crush site.  CAPs were measured post-
inhibitor application to assess whether inhibitor treatment alone, produced any restoration 
of CAP conduction.  Such treatments did not restore CAP conduction (data not shown).  
Following inhibitor treatments, PEG was applied to lesion and PEG-fusions were 
assessed by measuring CAP conduction through lesion site (PEG-fusion). 
%PEG-fusion CAP of Initial calculated using following equation:  (PEG-fusion CAP ∕ 
Initial CAP) x 100%.  n/a = assessment not applicable for treatment. 
 
Dye diffusion: To assess restoration of morphological continuity of crush-severed axons 
within the lesion site, in vitro (Britt et al. 2010; Spaeth et al. 2012), all nerves that 
received treatment and electrophysiological assessments in vivo (including Sham treated 
nerves) were excised and placed in dye diffusion apparatus (see Methods).  Yes - dye 
diffused through lesion site; No – dye did not diffuse through lesion site. 
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Sham 2 2.0 ± 0.0 n/a n/a n/a Yes 
Crush 4 2.2 ± 0.3 n/a n/a n/a No 
Crush+PEG 4 4.8 ± 0.1 No 0 0 No 
Crush+ηPSF+θPSF+PKI 4 6.3 ± 0.6 n/a n/a n/a Yes 
Crush+PKI+PEG 2 4.0 ± 1.5 No 0 0 No 
Crush+ηPSF+PEG 6 2.0 ± 0.1 No 0 0 No 
Crush+ηPSF+MB+PEG 6 1.3 ± 0.1 No 0 0 No 
Crush+θPSF+PEG 6 2.4 ± 0.6 No 0 0 No 
Crush+ηPSF+θPSF+PEG 2 4.5 ± 1.3 No 0 0 No 
Crush+ηPSF+θPSF+PKI+PEG 4 7.0 ± 1.5 No 0 0 Yes 
 
Table 3: CAP and dye diffusion data for treatment groups in which crush was performed 
with nerve bathed in Ca
2+
-containing physiological saline.  Immediately following crush 
injury, inhibitors of nPKCs or PKA (dissolved in hypotonic Ca
2+
-free physiological 






Summary of Results 
In this study we used an in vitro cell-based dye exclusion assay to determine if 
compounds that inhibit Ca
2+
-induced plasmalemmal sealing in neuronal B104 cells in 
vitro (Fig. 11A) could increase the probability of PEG-fusion of sciatic axons in vivo, 
following crush-severance in physiological calcium concentration (to realistically mimic 
peripheral nerve crush injury) (Table 3).  Inhibitors of nPKC η, θ and PKA decreased 
endogenous Ca
2+
-induced plasmalemmal sealing in B104 cells in vitro (Fig. 11A).  
Simultaneously inhibiting nPKC η, θ and PKA, dramatically decreased sealing, even 
when cells were transected in calcium in vitro (Fig. 11A, B).  Inhibitors of nPKC and 
PKA do not inhibit PEG-induced sealing in vitro (Fig. 11C, D).  However, when PEG 
was applied to cells transected in the combined presence of nPKC η, θ and PKA 
inhibitors, whether or not calcium was present during transection, all cells (intact and 
damaged) included Texas red dye suggesting that such treatment was cytotoxic in vitro 
(Fig. 11C, D).   
Given these in vitro data, we investigated whether nPKC η, θ and PKA inhibitor 
treatments could increase the probability of PEG-fusion following crush-severance in 
physiological calcium concentration.  We here report that applying inhibitors of nPKC 
and PKA (individually or in combination) to lesion sites immediately after crush-
severance in Ca
2+
-containing physiological saline, but prior to PEG application, do not 
promote PEG-fusion as assessed by CAP conduction and dye diffusion through lesion 
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sites (Table 3).  That is, we had 0% PEG-fusion success rate when PEG-fusion was 
attempted following crush in Ca
2+
-containing physiological saline. 
We also report that PEG-fusions were always observed for all treatment groups in 
which PEG was applied to lesion sites immediately after crush-severance in hypotonic 
Ca
2+
-free physiological saline, as assessed by CAP conduction and dye diffusion through 
the lesion site (Table 2; Figs. 12, 13).  That is, in this study we had 100% PEG-fusion 
success rate when PEG-fusion was performed following the  protocol set forth in Figure 
3.2 and as previously reported in Stavisky et al. (2005), Britt et al. (2010) and Bittner et 
al. (2012). 
 
Translation of PEG-fusion from laboratory to clinic 
We performed B104 cell in vitro and sciatic nerve in vivo experiments to 
determine if our current PEG-fusion protocol (Fig. 10) could be modified to successfully 
PEG-fuse axons crush-severed in physiological calcium concentration (~2 mM).  A 
strength of our cell-based assay is that we can quickly screen for proteins (or substrates) 
involved in endogenous sealing, that may be therapeutic targets for improving PEG-
fusion of severed axons.  A weakness of this assay is that the maximum effective 
concentrations of compounds used in vitro, such as those presented in this report for 
nPKC and PKA inhibitors, may not provide similar results in vivo, and may also have 
unforeseen cytotoxic effects on other cell types within the nerve and surrounding muscle. 
Although we are capable of obtaining nearly 100% PEG-fusion using our PEG-
fusion protocol, ex vivo and in vivo (Fig. 10; Britt et al. 2010; Bittner et al. 2012), it is by 
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no means a procedure that could be translated readily to emergency wards and operating 
theatres to provide immediate repair of traumatically crush-severed human peripheral 
nerves for a few very important reasons: 
1) Peripheral nerve crush injury is the most prevalent nerve injury (Taylor 
et al. 2008) commonly incurred in motor vehicle accidents (Campbell, 
2008). 
2)  Ambulance response times, specifically to motor vehicle accidents, 
are ≥ 8 minutes (Trowbridge et al. 2009). 
3)  Ca2+ influx at plasmalemmal disruptions of endogenous sealing is 
immediately induced and a complete seal formswithin 10 minutes 
(Yoo et al. 2003; Spaeth et al. 2010 and supplemental reference, 2012; 
Chapter 2).   
 
These statistics (1 – 3), highlight the obstacles impeding successful 
implementation of our PEG-fusion protocol (Fig. 10). 
 
Conclusion 
Our data suggest that much research and development are needed to translate our 
current PEG-fusion protocol into a successful neurotrauma treatment.  Specifically, the 
major obstacle to successful PEG-fusion of peripheral nerve crush or cut injuries seems 
to be, calcium-induced endogenous sealing.  To be able to reverse or slow endogenous 
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sealing, minutes after it has begun, could allow first responders (EMT) or surgeons the 
ability to apply PEG, minutes after traumatic injury, to closely apposed, re-opened 
(unsealed) axonal ends, to PEG-fuse severed axons.  We suggest that future studies of 
PEG-fusion and its feasibility as a neurotrauma therapeutic modality continue to 
implement cell-based screens because they can rapidly detect probable therapeutic 
targets.  Such assays in the future should investigate the effects of compounds that could 
reverse/weaken a formed plasmalemmal seal, such as Triton X-100 (a detergent), which 
is typically used in microbiology to permeabilize plasmalemmas.  Such a compound may 
be capable of weakening or reversing a seal, re-opening previously sealed axonal ends, 
providing a window of opportunity to PEG-fuse closely apposed severed axonal ends.  
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MATERIALS AND METHODS 
IN VITRO B104 CELL PREPARATIONS  
B104 cells: 
B104 cells derived from a CNS neuroblastoma (Bottenstein and Sato, 1979) have often 
been used as a model system to study neuronal function in vitro (Yoo et al. 2003; Nguyen 
et al. 2005; Miller et al. 2006; Spaeth et al. 2010). B104 cells extend neurites that have 
properties typical of nerve axons such as generation of action potentials, smooth (but not 
rough) endoplasmic reticulum, release of neurotransmitter, and regeneration of severed 
neurites. These cells have easily identifiable cell bodies and neurites, allowing precise 
identification of individually damaged cells at their injury site (Detrait et al. 2000b; Yoo 
et al. 2003, 2004; Spaeth et al. 2010). Unlike some other model neuronal cell lines (e.g., 
PC12 cells), B104 cells do not require growth factor supplements of fetal bovine serum to 
proliferate (Detrait et al. 2000b; Yoo et al. 2003; Spaeth et al. 2010). Data on sealing of 
B104 cells are consistent with similar data on sealing from at least 20 other preparations 




As described by  Nguyen et al. (2005) and Spaeth et al. (2010), B104 cells were grown in 
75 cm
2
 vented cap flasks (BD Falcon; BD Biosciences) in a humidified incubator at 37°C 
in 5% CO2 and in 4 ml of cell growth medium: consisting of a 1:1 mixture of Dulbecco’s 
modified Eagle’s medium and Ham’s F12 (DMEM:F-12, HyClone) supplemented for 
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growth with 10% heat-inactivated fetal bovine serum (FBS; HyClone) and 1% antibiotics 
(10,000 U of penicillin/ml and 10 mg/ml streptomycin; Sigma-Aldrich). The cell growth 
medium was changed every 2 d. Cultures were passaged at 80% confluency, and cells 
were then either subcultured in a vented cap flask or seeded at ~2000 cells/cm 
2
 in cell 
growth media on Petri dishes coated with poly-D-lysine (Sigma-Aldrich) to prevent cells 
from detaching during solution changes and/or neurite transection.  After 24 h, the 
growth medium was replaced with serum-free DMEM:F12 (Hyclone) to allow the B104 
cells to differentiate. B104 neurites were transected 24–48 h after replacing the cell 
growth medium with serum-free DMEM:F12. 
 
Transection of neurites of B104 cells: 
Before transecting neurites, the solution (DMEM:F12) in the Petri dish was washed twice 
with a Ca
2+
-free phosphate-buffered saline (referred to as “Ca
2+
-free saline,” PBS=; 
HyClone).   All neurites were transected in Ca
2+ 
-free saline at a distance >50 μm from 
the soma using a sharpened, pulled glass, micro capillary tube (“micro-knife”) that was 
placed on a micromanipulator (Narishige Instruments) and quickly drawn across the 
surface of the Petri dish, etching a score line that showed the path of the micro-knife. In 
all experiments, 3 kDa fluorescein dextran (Invitrogen) was added to the Ca
2+
-free saline 
during transection of B104 cell neurites to label cells damaged by the micro-knife.  As 
described previously (Yoo et al. 2004), only B104 cells with transected neurites uptake 
fluorescein dye, therefore we were able to uniquely and individually identify each B104 
 93 
cell with a transected neurite by fluorescein dextran fluorescence and the relation of the 
damaged cell/neurite to the score mark on the plate.  
 
Microscopic observations of dye exclusion: 
As previously described in Spaeth et al. (2010, 2012) for all experiments, B104 cells 
were observed under an inverted Zeiss ICM-405 fluorescent microscope with a 40X long 
focal distance lens.  Cells with neurites transected >50 μm from the soma were observed 
for fluorescein dextran uptake and Texas Red dextran in/exclusion. No further 
observations were made of transected cells that failed to uptake fluorescein dextran. 
 
Assessment of plasmalemmal sealing: 
As Spaeth et al. (2010) described, the most reliable measure of plasmalemmal repair, dye 
exclusion, was used to assay plasmalemmal sealing (Blanchette et al. 1999; Detrait et al. 
2000a,b).  To assess plasmalemmal repair, we transected 10–130 cells in Ca
2+
-free saline 
containing fluorescein dye within 10 min.  The Ca
2+
-free saline was then replaced with a 






; HyClone) to 
initiate the sealing process (Detrait et al. 2000b; Yoo et al. 2003; Spaeth et al. 2010, 
2012).  The time elapsed after exposing cells to Ca
2+
-saline is defined as the “post- Ca
2+ 
addition time” (PC time), ensuring that all cells on a given Petri dish have the same PC 
time.  After 5 minutes PC time, 3 kDa Texas Red dextran (Invitrogen) was added to the 
Ca
2+
-saline.  After a 10 min exposure, Texas Red dextran was thoroughly washed out 
with Ca
2+
-saline, and then sealing was assessed.  Transected cells (damaged neurite, 
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green fluorescence) that excluded Texas Red dextran were counted as “sealed”.  Cells 
that did not exclude Texas Red dextran were counted as “not sealed”. Proximate 
undamaged cells never took up Texas Red dextran.  As stated previously (Spaeth et al. 
2010), fluorescent dyes of higher molecular weight are excluded faster than lower 
molecular weight dyes (Detrait et al. 2000a; Yoo et al. 2003) at the same PC time.  Thus, 
to decrease variability in assessment of sealing probabilities for various treatments, based 
on dye exclusion, we consistently used 3 kDa Texas Red dextran in all experiments. 
 
Pharmacological reagents: 
We used pharmacological agents to inhibit or activate target proteins to avoid 
complications of compensatory pathways that may result from gene knock-outs or 
chronic applications of pharmacological inhibitors (Steinberg et al. 2008). All 
pharmacological reagents were typically dissolved in Ca
2+
-free saline and added to cells 
immediately before neurites were transected to backload cells with each reagent during 
transection. We used the following isozyme specific peptide inhibitors of PKC, 
purchased from EMD Chemicals, Gibbstown, NJ: myristoylated nPKCη pseudosubstrate 
fragment (7 μM, 2 kDa) was used to inhibit nPKCη (Liu et al. 2006; Barros et al. 2009; 
Spaeth et al. 2010), myristoylated nPKCθ pseudosubstrate fragment (9 μM, 2.3 kDa) to 
inhibit nPKCθ (Staal et al. 2008; Barros et al. 2009).  PKI (50 μM, 1.8 kDa; Sigma-
Aldrich; a generous gift from Drs. Michael Markham and Harold Zakon, University of 
Texas, Austin, TX) was used to specifically inhibit PKA (Spaeth et al. 2010).  A 50% 
stock solution of polyethylene glycol 2000 (PEG 2kDa; Fluka, Sigma Aldrich) was made 
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in double-distilled H2O (5 g PEG 2000 in 5 mL of ddH2O).  In-dish concentration of PEG 
was 10 mM (Spaeth et al. 2012). 
 
Statistical analyses: 
As described previously (Spaeth, 2010), we obtained data from individual, uniquely 
identified B104 cells that all received similar, well-specified, neurite transections as 
plasmalemmal injuries in a tightly controlled environment. For each treatment group, at a 
given PC time the data were pooled for all cells (n) from all Petri dishes (N).  See Table 
4 below, for n and N values for each data set at 5 min PC time point in Figure 11.  
“Sealing probability” is defined as the percentage of a set of individually-transected and 
uniquely identified cells that exclude 3 kDa Texas Red dye (sealed) at a given PC time. 
As described previously (Detrait et al. 2000b; Yoo et al. 2003, 2004; Spaeth et al. 2010, 




) test for independence was used to 
determine differences among sealing probabilities at a given PC time for different 
experimental treatments were statistically significant (p < 0.05), as previously described 
(Agresti, 1996; Detrait et al. 2000; Yoo et al. 2004; Spaeth et al. 2010, 2012). The CMH 
χ
2 
test for independence is used to compare data separated into two-by-two contingency 
tables (sealed or not sealed, and control vs. experimental data sets). This test entails 
binary outputs, applied to our sealing assay (sealing is treated as a yes or no event at a 
given PC time). Because sealing of a given cell and not each Petri dish (sometimes 
containing over 100 transected cells) are independent events, measures of variance (such 
as SE or SD) are not applicable. 
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PEG (2, 164) (2, 172) 
η PSF (3, 108) (2, 153) 
θ PSF (2, 185) (2, 162) 
η PSF + θ PSF (2, 140) (2, 246) 
PKI (3, 113) (2, 157) 
η PSF + θ PSF + PKI  (2, 116) (2, 134) 
η PSF + PEG (2, 201) (2, 130) 
θ PSF + PEG (2, 171) (2, 137) 
η PSF + θ PSF + PEG (2, 171) (2, 141) 
PKI + PEG (2, 130) (2, 145) 
η PSF + θ PSF + PKI + PEG # # 
 
Table 4:  The numbers in parentheses (N, n) represent the number of Petri dishes (N) 
used to obtain sealing data from (n) transected B104 cells.  The total number of cells (n) 
listed per condition were obtained by combining the sum of all cells counted (sealed or 
not sealed) from each dish per treatment at 5 min PC time.  Blank space: no experiments 
performed for condition at designated PC time.  “#” indicates cells were transected for 
these treatments however, treatments proved cytotoxic; thus no cells were counted as 
sealed or not sealed following dye wash-out. 
 
IN VIVO OR IN VITRO PREPARATIONS OF RAT SCIATIC NERVES 
All procedures were approved by the University of Texas at Austin’s Institutional 
Animal Care and Use Committee (Protocol no. AUP-2010-00183).  All animals were 
housed in groups of three in polycarbonate cages with sawdust bedding, maintained on a 
12:12 dark/light cycle, and given food and water ad libitum. 
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Surgical procedures: 
As previously described in Bittner et al. (2012), Sprague Dawley rats were anesthetized 
with intra-peritoneal injections of ketamine (90 mg/kg) and xylazine (10 mg/kg).  The 
sciatic nerve was exposed by an incision about 1.5 cm long in posterior-thigh muscles of 
the hind limb.  Exposed sciatic nerves were cleaned of connective tissue and bathed with 
hypotonic Ca
2+
-free (Table 2) or Ca
2+
-containing (Table 3) Krebs physiological saline 
perfused from a Pasteur pipette.  One liter of hypotonic Ca
2+
-free saline contained in 
mM:  0.5 EGTA, 124 NaCl, 5 KCl, 1.2 KH2PO4, 1.3 MgSO4, 26 NaHCO3, 10 Na 
ascorbate, 10 dextrose, 2 MgCl2, pH 7.35, 295 mOsm dissolved in double distilled H20 
(ddH20).  One liter of isotonic Ca
2+
-containing saline contained in mM:  124 NaCl, 5 
KCl, 1.2 KH2PO4, 1.3 MgSO4, 26 NaHCO3, 10 Na ascorbate, 10 dextrose, 2 CaCl2, pH 
7.35, 345 mOsm dissolved in ddH20.  We confirmed in anesthetized animals that 




-containing saline conducted 
action potentials across the site of any intended lesion (see CAPs below).  Animals in the 
Sham group received no nerve injury following exposure of the sciatic nerve via a skin 
incision.  Throughout all procedures, the nerve was moistened with the appropriate 
saline, e.g. nerves in Table 2 received hypotonic Ca
2+
-free saline during exposure of 
nerve and crush injury, but then received Ca
2+
-containing saline after PEG application; 
nerves in Table 2 received Ca
2+
-containing saline during exposure of nerve, during crush 
injury and, after PEG application 
Sciatic crush-severance injuries were made with Dumont #5 forceps, applying 
enough force to sever every axon. The crush-severance site about 1 mm long was much 
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less opaque than adjacent uninjured sites viewed at 20-50x through a dissecting 
microscope.  After crush injury, the sciatic nerve was again assessed for CAP conduction 
across the lesion site.  If a CAP was detected, the nerve was crushed again.  To apply 
treatment solutions containing nPKC and PKA inhibitors or PEG in hypotonic Ca
2+
-free 
saline , or isotonic Ca
2+
-containing saline to crush-severed sciatic axons, the epineurial 
sheaths of crush-severed sciatic nerves were nicked at the lesion site with microdissection 
scissors to allow better access of solutions to the crush-severed axons.  
For animals treated with 7 µM ηPSF (EMD-Calbiochem), 9 µM θPSF (EMD-
Calbiochem) or 50 µM PKI (Sigma-Aldrich), compounds were dissolved in 1 mL of 
hypotonic Ca
2+
-free saline and applied from a micropipette positioned 1-5 mm above the 
nick in the nerve’s epineurial sheath so that the solution flowed in a narrow stream (about 
1 mm wide) for 1-3 min over the crushed axons at the lesion site. Treatments of 500 mM 
PEG (2 kDa PEG, Fluka, SigmaAldrich) dissolved in ddH2O were then applied to the 
lesion site via a similar micropipette so that the denser PEG-containing solution flowed 
for 1.5-2 min over the lesion site.  After such treatments, a second pipette was used to 
perfuse the sciatic nerve with isotonic Ca
2+
-containing saline.  
  
500 mM (50% w/v) Polyethylene glycol (PEG) solution: 
5 g of PEG 2000 dissolved in 5 mL of ddH20 (Britt et al. 2010; Bittner et al. 2012).   
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Treatment groups and their rationale: 
Crush-severed rat sciatic nerves were assayed in vivo (CAP conduction) or ex vivo (Dye 
Diffusion).  Some were left untreated (Crush), some did not receive PEG following 
compound treatment (Crush+ ηPSF+ θPSF+PKI).  Other crush-severed nerves were 
treated with  PEG (Crush+PEG) or with nPKC and PKA inhibitors, individually or in 
combination, prior to PEG as indicated: 7 µM ηPSF (Crush+ ηPSF+PEG), 9 µM θPSF 
(Crush+ θPSF+PEG), 7 µM ηPSF and 9 µM θPSF (Crush+ ηPSF+ θPSF+PEG), 50 µM 
PKI (Crush+PKI+PEG),  or 7 µM ηPSF and 9 µM θPSF and 50 µM PKI (Crush+ ηPSF+ 
θPSF+PKI+PEG).  Crush and Crush+PEG treatment groups were used as experimental 
controls for qualitative comparisons of CAP conduction and dye diffusion assessments.   
All treated groups were compared to the Crush treatment group to assess possible PEG-
fusion success. 
 
Electrophysiological recording of CAPs: 
Electrophysiological recordings of CAPs conducting across a lesion site in vivo were 
made by two pairs of nickel-tipped hook electrodes placed on or beneath the sciatic nerve 
to stimulate and record CAPs, which were displayed on an analog (Tektronix 502A, Lore 
et al. 1999; Marzullo et al. 2002; Britt et al. 2010; Bittner et al. 2012) or digital (AD 
Instruments PowerLab 4/35 with Lab Chart Pro analysis software) oscilloscope.  All 
lesions were made between the two stimulating and recording hook electrodes. Complete 
crush-severance of all axons was confirmed by an inability to record a detectable CAP 
conducted through the lesion site.  The sciatic nerve was always stimulated after any 
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treatment to determine if CAPs conducted through the lesion site. During pre-operative 
and post-operative CAP recordings in vivo, the nerve was continuously moistened with 
appropriate physiological saline.  
To correlate a measure of electrophysiological continuity with a measure of 
morphological continuity we recorded CAPs from nerves, then following treatments, 
excised these same nerves (n = 48)  to assess morphological continuity with an intra-
axonal dye diffusion assay (see description in following section). 
 
Figure 14: CAP recordings as visualized 






Intra-axonal dye diffusion across a lesion site: 
After recording CAPs, we correlated in vivo CAP conduction with ex vivo intra-axonal 
dye diffusion through the lesion site.  This was obtained by excising a 2-4 cm length of 
the sciatic nerve (including lesion sites) from animals (Lore et al. 1999; Britt et al. 2010; 
Spaeth et al. 2012).  The proximal end of the sciatic nerve segment was placedin a 
petroleum jelly (Vaseline) ring containing Ca
2+
-free saline and 100 μL of hydrophilic dye 
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(2kDa Texas red dextran, Molecular Probes).  The remainder of the nerve, including any 
crush-severance site, was bathed in Ca
2+
-containing saline.  The Petri dish containing the 
nerve in the Vaseline well was refrigerated for 14 hours at 4˚C.  Nerves were examined 
for intra-axonal diffusion of fluorescent dye beyond the crush lesion site using a Zeiss 
ICM-405 inverted fluorescence microscope.  Some nerves were imaged using a Nikon 
TS100F inverted fluorescent microscope (Nikon Instruments Inc., Melville, NY) 
equipped with a rhodamine filter and DS Fi-2 fluorescence color camera. 
 
Statistical Analyses: 
As previously described (Britt et al. 2010; Bittner et al. 2012), Student’t T-test with 
Bonferroni’s correction for multiple comparisons was used to compare statistical (p < 
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Chapter 4: Preliminary Study: Role of nPKC η and θ in 
neuroprotective sealing of ischemia-induced plasmalemmal damage 
SUMMARY 
Oxygen-glucose deprivation (OGD) is often used in vitro to mimic ischemic 
stroke.  OGD-induced plasmalemmal damage has been extensively described in many 
eukaryotic cell types in early studies of stroke.  However, no study has investigated the 
cellular mechanisms that promote repair (sealing) of OGD-induced plasmalemmal 
damage.  We exposed cells to normoxia (atmospheric O2; 0mM glucose) or, immediate 




phosphate buffered saline (PBS
=
).  Following OGD 
exposures, we assessed sealing as the ability of cells to exclude extracellular dye.  We 





following 1, 3, 5 or 10 minutes of OGD exposure, did not have significantly different 
sealing probabilities compared to cells maintained in PBS
=
 following similar OGD 
exposures.  Cells exposed to 10 minutes of immediate OGD only, had significantly 
(p<0.001; CMH χ
2
) decreased sealing probability compared to normoxic controls (74% 
vs. 98%, respectively).  Lastly, cells exposed to 1, 3, 5 or 10 minutes of OGD in the 
presence of nPKC η or θ peptide inhibitors had significantly decreased sealing 
probabilities compared to normoxic controls (p<0.001 for 1, 3, 10 min; p<0.01 for 5 min; 
CMH χ
2
) and, cells exposed to OGD only.  These data show that extent of OGD-induced 
plasmalemmal damage in B104 cells is dependent upon duration of OGD exposure and, 
that sealing of OGD-induced plasmalemmal damage is promoted by nPKC η and θ – 
similar to sealing of transected neurites of B104 cells. 
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INTRODUCTION 
Stroke is the third leading cause of death in the USA (Roger, 2006; Janardhan and 
Qureshi, 2004).  Clinical data show that 87% of all documented strokes in the USA are 
ischemic (NHLBI, 2006).  It is well documented that ischemia (oxygen glucose 
deprivation; OGD) produces plasmalemmal damage (Hoffstein, 1975; Chien, 1978; 
Farber, 1981; Herman, 1988; Neiminen, 1988; Zahrebelski, 1995; Wang, 1996; 
Nishimura, 2001; Rodriguez-Sinovas, 2005).  OGD-induced plasmalemmal disruptions 
are easily observed as membrane blebs, in vitro (Neiminen, 1988).  As an ischemic event 
progresses, the integrity of cell plasmalemmas worsen, blebs form, grow, coalesce and 
eventually burst, releasing cytoplasmic contents.  Such plasmalemmal damage occurs 
often in humans (see above), resulting in loss of functional behavior.  However, 
increasing cells ability to repair (seal) their damaged plasmalemma can decrease the 
severity of tissue damage and increase functional behavior recovery (Nehrt, 2010; Britt, 
2010). 
To model ischemia in vitro, cells are often incubated in an anaerobic (0% oxygen) 
chamber at 37°C in media lacking glucose (0% glucose) (Jones, 2004). Cells are then 
returned to normoxic conditions – simulating reperfusion.  Such OGD exposures increase 
Ca
2+
 influx, calpain activity, membrane permeability, membrane damage and cell death 
(Yoshioka, 2000; Cao, 2010).  Several studies have previously demonstrated that 
fluorescent dyes label cells with OGD-induced plasmalemmal damage (Hoffstein, 1975; 
Chien, 1978; Farber, 1981; Herman, 1988; Neiminen, 1988; Zahrebelski, 1995; Wang, 
1996; Nishimura, 2001; Rodriguez-Sinovas, 2005; Cao, 2010). 
 108 
Similarly, studies on plasmalemmal sealing have shown, by use of fluorescent dye 
exclusion assays, that Ca
2+
 influx (Eddleman, 1998; Detrait, 2000a,b; McNeil, 2001) 
through plasmalemmal disruptions induces plasmalemmal sealing by vesicle-mediated 
repair (Steinhardt, 1994): vesicles from nearby undamaged membrane (Eddleman, 1997, 
1998), lysosomes (Reddy, 2001), and/or myelin delaminations (Ballinger, 1997) migrate, 
accumulate, and pack tightly (likely through the interactions of SNAREs) at the damage 
site to reduce the influx of extracellular Ca
2+
 and other ions until plasmalemmal 
continuity is restored.  We have also reported that vesicle-mediated repair of 
plasmalemmal damage is promoted by calpain (Godell, 1997), novel protein kinase C 
isozyme η (nPKC η), protein kinase A (PKA), and cAMP (Spaeth, 2010), as well as, 
nPKCθ, DAG, MARCKS and Munc13-1 (Chapter 2). 
We have recently used the murine hippocampal B104 cell line to investigate 
proteins and substrates that influence plasmalemmal sealing, in vitro, by transecting a 
single neurite (axon-like projection) of a B104 cell and assessing the cell’s ability to 
exclude an extracellular dye (Yoo, 2003, 2004; Nguyen, 2005; Spaeth, 2010, 2011).  We 
have now translated our work on sealing of transected neurites to test the hypothesis that, 
the same proteins and substrates involved in sealing damaged (transected) B104 neurites 
should also promote sealing of OGD-induced plasmalemmal damage in B104 neurons.  
We now report that, unlike sealing of transected B104 neurites, the presence of Ca
2+
 
following immediate OGD exposures of 1, 3, 5 or 10 minutes, did not promote sealing 
probability in B104 cells compared to cells not receiving Ca
2+
 following similar OGD 
exposures.  However, cells exposed to peptide inhibitors of nPKC η or θ, during OGD 
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exposures of 1, 3, 5 or 10 minutes had significantly decreased sealing probability 
compared to normoxic (no treatment) controls and, cells exposed to OGD only.  These 
data suggest that nPKC η and θ promote sealing of OGD-induced plasmalemmal damage 
in B104 cells, as they do for sealing of transected neurites of B104 cells. 
 
RESULTS 
 For all plasmalemmal sealing data (sealing probability) shown, B104 cells were 





) and sometimes, in the presence of previously identified sealing 
inhibitors or enhancers (Spaeth, 2010; Chapter 2) dissolved in PBS
=
.  Following such 
exposures, cells were returned to normoxia, typically in normoglycemic phosphate 




) or, sometimes in normoglycemic PBS
=
.  Five minutes 
after return to normoxia, Texas Red dextran dye (neutral, 3kDa) was added to each dish.  
Cells were exposed to dye for no longer than 10 minutes; dye was rinsed from dishes 
using respective normoxic saline.  We assessed sealing as the ability of viable B104 cells 
(i.e., the cell must have an intact plasmalemma) to exclude extracellular dye.  The total 
number of viable cells (n), sealed and unsealed, were pooled from (N) number of dishes 
used for each condition (Table 5).  From the total, pooled number of cells per treatment, 




Table 5: Sealing probabilities and total number of plates and cells (N, n) observed per 
OGD condition. 
 
Duration of exposure (minutes) to Treatments 
Treatments 1 3 5 10 
Normoxic control (PBS
=
 → PBS2+) 
99% (4, 439; Fig. 16) 
100% (12, 1346; Fig. 
17) 
99% (5, 532; Fig. 16)   
99% (13, 1379; Fig. 
17) 
99% (7, 765; Fig. 16)  
99% (5, 469; Fig. 17) 
98% (4, 404; Fig. 16)  
98% (4, 400; Fig. 17) 
OGD (PBS
=
 → PBS2+) 
99% (2, 257; Fig. 16) 
100% (4, 436; Fig. 
17) 
98% (4, 408; Fig. 16)                                               
96% (8, 810; Fig. 17) 
99% (2, 197; Fig. 16)
99% (2, 200; Fig. 17) 
74% (4, 456; Fig. 16)      
74% (4, 403; Fig. 17) 














) 99% (2, 200) 100% (2, 204) 98% (2, 200) 82% (4, 407) 
Following data shown in Figure 3 
only     
Normoxia (PBS
=
 + ηPSF → PBS2+) 98% (4, 441) 98% (4, 427) 99% (4, 412) 96% (4, 411) 
Normoxia (PBS
=
 + θPSF → PBS2+) 100% (4 ,429) 98% (4, 436) 97% (4, 413) 97% (4, 429) 
OGD (PBS
=
 + ηPSF → PBS2+) 86% (4, 417) 91% (4, 405) 64% (7, 589) 52% (4, 422) 
OGD (PBS
=
 + θPSF → PBS2+) 87% (2, 317) 88% (3, 299) 81% (6, 541) 45% (4, 411) 
OGD (PBS
=
 + ηPSF + θPSF → 
PBS2+) 
94% (4, 416) 85% (4, 409) DNC DNC 
 
*DNC = Did Not Count plates; treatment consistently caused cell death on all dishes (at least 4 
plates per OGD exposure).  
Statistically significant differences between normoxic control (no treatment) and 





; Spaeth, 2010, 2011; Chapter 2) test for 
independence (Table 6).  Statistically significant differences between normoxic control 
and experimental treatments, only, are indicated on graphs with asterisks (*, p<0.05; **, 
p<0.01; ***, p<0.001).  Lastly, for all abbreviations of control and experimental 
treatments in the results, phrases preceding a solid arrow () indicate the experimental 
or control treatment.  The arrow always indicates return to normoxia and, phrases 
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following the arrow indicate the type of phosphate buffered saline used during return to 




), indicates that cells were exposed to 
OGD in PBS
=









Comparison of sealing probabilities after duration of exposure (minutes) to 
Treatments 
Treatment comparisons for data shown in Figure 2 1 3 5 10 
Normoxic control (PBS
=






99% vs. 99%         
NS 
99% vs. 100%        
NS 
99% vs. 98% NS 





 → PBS2+) 
99% vs. 99% NS 99% vs. 98% NS 99% vs. 99% NS 












99% vs. 99% NS 
100% vs.100%          
NS 
98% vs. 98% NS 88% vs. 82% NS 
OGD (PBS
=






99% vs. 99% NS 
98% vs. 100% 
NS 
99% vs. 98% NS 74% vs. 82% NS 
Treatment comparisons for data shown in Figure 3 
    Normoxia (PBS
=
 + ηPSF → PBS2+) 
vs. Normoxic control 
98% vs. 100% 
NS 
99% vs. 99% NS 99% vs. 99% NS 96% vs. 98% NS 
OGD (PBS
=
 + ηPSF → PBS2+) 
vs. Normoxic control 
86% vs. 100% 
p<0.001 
91% vs. 99% 
p<0.01 
64% vs. 99% 
p<0.001 




 + ηPSF → PBS2+) 
vs. OGD (PBS
=
 → PBS2+) 
86% vs. 100% 
p<0.01 
91% vs. 96% NS 
64% vs. 99% 
p<0.001 




 + θPSF → PBS2+) 
vs. Normoxic control 
100% vs. 100% 
NS 
98% vs. 99% NS 97% vs. 99% NS 97% vs. 98% NS 
OGD (PBS
=
 + θPSF → PBS2+) 
vs. Normoxic control 
87% vs. 100% 
p<0.001 
88% vs. 99% 
p<0.01 
81% vs. 99% 
p<0.001 




 + θPSF → PBS2+) 
vs. OGD (PBS
=
 → PBS2+) 
87% vs. 100% 
p<0.001 
88% vs. 96% NS 
81% vs. 99% 
p<0.001 




 + ηPSF → PBS2+) 
vs. OGD (PBS
=
 + θPSF → PBS2+) 
86% vs. 87%  
NS 
91% vs. 88%         
NS 
64% vs. 81% 
p<0.05 
52% vs. 45% NS 
OGD (PBS
=
 + ηPSF + θPSF → PBS2+) 
vs. Normoxic control 
94% vs. 100% 
p<0.05      





 + ηPSF + θPSF → PBS2+) 
vs. OGD (PBS
=
 → PBS2+) 
94% vs. 100% 
p<0.05  





 + ηPSF + θPSF → PBS2+)  
vs. OGD (PBS
=
 + ηPSF → PBS2+)  
94% vs. 86% 
p<0.05 
85% vs. 91% NS NC NC 
OGD (PBS
=
 + ηPSF + θPSF → PBS2+) 
vs. OGD (PBS
=
 + θPSF → PBS2+) 
94% vs. 87% 
p<0.05 
85% vs. 88% NS  NC NC 
Table 6: Statistically significant differences between normoxic control and experimental 
treatments are indicated on graphs with asterisks (*, p<0.05; **, p<0.01; ***, p<0.001). 
NS = No statistical significance.  NC = No comparison made because treatment [OGD 
(PBS
=
 + ηPSF + θPSF → PBS
2+
)] caused extensive cell death. 
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OGD exposures did not adversely affect cell morphology 
 We first assessed if decreased sealing probability (i.e., increased dye inclusion) 
caused by increased OGD exposures were attributable to extensive plasmalemmal 
damage resulting in blebbing and loss of cell morphology – typical signs of non-viable 
cells.  We compared cells prior to OGD exposure (Fig. 15A), to cells after 1, 3, 5 or 10 
minutes of OGD exposure (Fig. 15B-E) and did not observe any difference in cell 
morphology between cells prior to or after OGD exposure.  Lastly, viable cells including 
dye (i.e., did not seal) did not show signs of blebbing or morphological changes 
compared to viable, sealed cells (Fig. 15H, I). 
 114 
Figure 15: Images of B104 cells before and after OGD exposure 
A-E: Taken before (A) or, after 1 minute (B), 3 minutes (C), 5 minutes (D) or, 10 minutes (E) of OGD 
exposure. Scale bar 100 μm at 10x magnification.  
F, G: Images of cells that have retained (viable, F) or lost (non-viable, G) morphology following ischemic 
insult.   F-I: Scale bar 50 μm at 60x magnification. 
H-I: Light (H) and fluorescence (I) images of adjacent cells that sealed (white diamond) or did not seal 




 following OGD did not increase sealing of OGD-induced 
plasmalemmal damage 
 Studies of plasmalemmal sealing in various vertebrate and invertebrate 
preparations (Krause, 1994; Eddelman, 1997; Steinhardt, 1994; Togo, 2003), including 




at plasmalemmal damage sites is required to promote sealing at such damage sites.  Since 
OGD causes plasmalemmal damage, we determined if Ca
2+
 promoted sealing of OGD-
induced plasmalemmal damage in B104 cells.  We first determined the effect of the 
presence or absence of Ca
2+
 on normoxic controls.  B104 cells were exposed to normoxia 
(0% glucose, atmospheric O2) in PBS
=
 for 1, 3, 5 or 10 minutes, following such 
exposures, PBS
=




, cells were maintained under 
normoxia, and dye was added 5 minutes after media exchange.  B104 cells receiving Ca
2+
 






















 exposure (Table 6; Fig. 16, compare unfilled, 
gray circles to, unfilled, black circles).  No statistically significant difference (p>0.05, 
CMH χ
2
) in sealing probability was observed between B104 cells receiving or not 
receiving Ca
2+
 after 1, 3 or 5 minutes exposure to normoxia in PBS
=
 (Table 6; Fig. 16). 
From here on, all treatments are compared to the normoxic control receiving Ca
2+
 
following exposure to normoxia in PBS
=
; referred to as “normoxic control” sealing and 




) in all graphs and, Normoxic control in all 
tables.  
 We next determined if Ca
2+
 addition, following exposure to OGD in PBS
=
, 
promoted sealing of OGD-induced plasmalemmal damage.  B104 cells receiving Ca
2+
 






) had significantly 
(p<0.001, CMH χ
2
) decreased sealing probability (74% vs. 98%) compared to normoxic 
control sealing (Table 6; Fig. 16). B104 cells not receiving Ca
2+








) had significantly (p<0.001, CMH χ
2
) decreased 
sealing probability (82% vs. 98%) compared to normoxic control sealing (Table 6; Fig. 
16).  Lastly, no statistically significant difference (p>0.05, CMH χ
2
) in sealing 
probabilities was observed between B104 cells receiving or not receiving Ca
2+
 after 1, 3, 
5 or 10 minutes exposure to OGD in PBS
=
 (Fig. 16, compare filled to unfilled diamonds).      
 
Figure 16: Sealing probability (%) vs. Normoxia or OGD exposure (min). 
Effect of Ca
2+
 addition following normoxia or OGD in Ca
2+
-free phosphate buffered saline.  Normoxic 
control sealing (gray, unfilled circles and dashed line) on this and all other graphs.   
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Inhibition of η or θ PKC during oxygen-glucose deprivation decreased post-
ischemic plasmalemmal repair 
 We have recently shown that inhibition of nPKC η (Spaeth, 2010) or nPKCθ 
(Chapter 2) decreased sealing of transected neurites of B104 cells – suggesting these 
nPKC isozymes promote plasmalemmal sealing.  To this end, we determined if nPKC η 
or θ promotes sealing of OGD-induced plasmalemmal damage in B104 cells.  We first 
determined the effect of nPKC η or θ pseudosubstrate fragments (ηPSF, Spaeth, 2010; 
θPSF, Staal, 2008; Barros, 2009) on B104 cells under normoxia.  B104 cells were 
exposed to normoxic conditions (0% glucose, atmospheric O2) in PBS
=
 for 1, 3, 5 or 10 





, cells were maintained under normoxia, and dye was added 5 
minutes after media exchange.  B104 cells exposed to ηPSF or θPSF for 1, 3, 5 or 10 
minutes under normoxia had no statistically significant (p>0.05, CMH χ
2
) difference in 
sealing probabilities compared to normoxic sealing (Table 6; Fig. 17, compare unfilled 
triangle and unfilled, black circle to, unfilled, gray circle).    
 We determined if the presence of ηPSF during OGD in PBS
=
, inhibited sealing of 





 + ηPSF  PBS
2+
) had significantly decreased sealing probability after 1, 3, 
5 and 10 minutes (p<0.01,p<0.01, p<0.001, and p<0.001, respectively, CMH χ
2
) of 
exposure compared to normoxic control sealing (Table 6; Fig. 17, compare filled 
triangles to, unfilled, gray circles).  Furthermore, exposure to ηPSF during OGD 
significantly decreased sealing probability after 1, 5 and 10 minutes (p<0.01, p<0.001 
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of exposure compared to cells exposed to OGD only 
(Table 6; Fig. 17, compare filled triangles to, unfilled diamonds).   
 Next, we determined if the presence of θPSF during OGD in PBS
=
, inhibited 





 + θPSF  PBS
2+
) had significantly decreased sealing 
probability after 1, 3, 5 and 10 minutes (p<0.001, p<0.01, p<0.001, and p<0.001, 
respectively, CMH χ
2
) of exposure compared to normoxic control sealing (Table 6; Fig. 
17, compare filled circles to, unfilled, gray circles).  Furthermore, exposure to θPSF 
during OGD significantly (p<0.001, CMH χ
2
) decreased sealing probability after 1, 5 and 
10 minutes of exposure compared to cells exposed to OGD only (Table 6; Fig. 17, 
compare filled triangles to, unfilled diamonds).  No statistically significant difference 
(p>0.05, CMH χ
2
) in sealing probabilities was observed, when comparing B104 cells 
exposed to OGD in PBS
=
 in the presence of ηPSF, to cells exposed to OGD in PBS
=
 in 
the presence of θPSF (Table 6; Fig. 17, compare filled circles to filled triangles), except 
at 5 minutes (p<0.05, CMH χ
2
). 
Lastly, we determined if the presence of ηPSF and θPSF during OGD in PBS
=
, 
would produce even greater inhibition on sealing of OGD-induced plasmalemmal 




 + ηPSF 
+ θPSF → PBS
2+
) had significantly decreased sealing probability after 1 and 3 minutes 
(p<0.05 and, p<0.01 respectively, CMH χ
2
) of exposure compared to normoxic control 
sealing (Table 6; Fig. 17, compare X to, unfilled, gray circles).  Furthermore, exposure to 
ηPSF + θPSF during OGD significantly (p<0.05, CMH χ
2
) decreased sealing probability 
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after 1 and 3 minutes of exposure compared to cells exposed to OGD only (Table 6; Fig. 
17, compare X to, unfilled diamonds).  However, all cells exposed to OGD and ηPSF + 
θPSF for 5 minutes died, suggesting plasmalemmal integrity was significantly effected by 
this treatment. 
 
Figure 17: Sealing probability (%) vs. Normoxia or OGD exposure (min) in PKC 
inhibitors. 
Effect of ηPSF or θPSF during OGD in PBS
=




In this study we induced plasmalemmal damage in B104 cells by exposure to 
ischemic (oxygen and glucose deprivation; OGD) insult, sometimes in the presence of 
specific peptide inhibitors of nPKC isozymes η and θ, to determine the role of such nPKC 
isozymes in sealing of OGD-induced plasmalemmal damage.  We now report that the 
presence of nPKC η or θ peptide inhibitors, during all OGD exposures (1, 3, 5 or 10 min), 
decreased sealing probabilities compared to both normoxic control and cells exposed to 
OGD only (Table 6; Fig. 17).  Furthermore, exposing cells to OGD in the presence of 
both ηPSF + θPSF further decreased sealing probabilities compared to either inhibitor 
alone.   These data suggest that nPKC η and θ promote sealing of OGD-induced 
plasmalemmal damage in B104 cells.  Furthermore, our data suggest that sealing of 
plasmalemmal damage in B104 cells, whether transection- (Spaeth, 2010; Chapter 2) or 
OGD-induced, occurs via a universal mechanism that requires nPKC η and θ. 
 
OGD exposure: Viable vs. Non-viable cells 
Ischemia (OGD) is well known to produce easily observable plasmalemmal 
damage such as, membrane blebs, loss of cell morphology and extracellular dye inclusion 
(Hoffstein, 1975; Chien, 1978; Farber, 1981; Herman, 1988; Neiminen, 1988; 
Zahrebelski, 1995; Wang, 1996; Nishimura, 2001; Rodriguez-Sinovas, 2005).  However, 
following acute OGD exposures, viable B104 cells did not exhibit blebbing or loss of cell 
morphology (Fig. 15A-E), even in cells including extracellular dye (Fig. 15H, I).  
Furthermore, only non-viable B104 cells (not used in this study) demonstrated blebbing, 
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loss of cell morphology or cytoplasmic contents -- typically after 10 min OGD exposure 
(images not shown).  These data suggest that most cells were capable of sealing 
(repairing) plasmalemmal damage caused by such OGD-exposures.  And, that decreased 
sealing probability (increased dye inclusion) caused by increased OGD exposure and 
presence of nPKC η or θ peptide inhibitors during OGD exposure, was likely caused by 
an increase in the number of plasmalemmal damage sites and inhibition of sealing, not 
loss of viability -- as demonstrated by maintenance of cell morphology and lack of 
blebbing in cells including dye after OGD exposures (Fig. 15H, I). 
 
With or without Ca
2+
: B104 cells seal OGD-induced plasmalemmal damage 
 As stated previously, plasmalemmal sealing in vertebrate and invertebrate 
preparations (Krause, 1994; Eddelman, 1997; Steinhardt, 1994; Detrait, 2000b: Togo, 
2003), including B104 cells (Nguyen, 2005; Spaeth, 2010; Chapter 2), is induced by Ca
2+
 
influx at plasmalemmal damage sites.  We expected that sealing of OGD-induced 
plasmalemmal damage would increase when cells exposed to OGD were returned to 
normoxia in the presence of Ca
2+
.  However, data in Figure 16 show that B104 cells have 
similar sealing probabilities (Table 6) of OGD-induced plasmalemmal damage when 
returned to normoxia in the presence or absence of Ca
2+
.  A plausible explanation for this 
unexpected result may be that 1, 3, 5 or 10 min exposures to OGD create many, small 
plasmalemmal damage sites (large enough for 3 kDa Texas Red dextran dye to enter) that 
require few vesicles and little to no increase in local [Ca
2+
]i to be sealed.  As reported 
previously, it is possible to promote sealing in the absence of Ca
2+
: addition of a DAG- 
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(Chapter 2) or cAMP- (Spaeth, 2010) analog to cell media following neurite transection 
promoted sealing in the absence of Ca
2+
.  However, in both cases, neither increased DAG 
nor cAMP concentrations could substitute for Ca
2+
, which is required to maintain cell 
viability. 
Thus, it is plausible that OGD-induced plasmalemmal damage activates a Ca
2+
-
independent mechanism that increases DAG- or cAMP-dependent sealing pathways 
(Spaeth, et al., 2010), such as cytosolic oxidation (Spaeth et al., 2011).  Cytosolic 
oxidation may enhance DAG-dependent proteins such as nPKC η and θ and, Munc13-1 
(Chapter 2).  As reported in Spaeth et al. (2011) cytosolic oxidation does enhance cAMP-
dependent sealing via proteins such as Epac and PKA (Spaeth, 2010). Therefore, 
cytosolic oxidation may promote sealing of OGD-induced plasmalemmal damage 
without requiring large increases in [Ca
2+
]I to induce sealing.  Testing of longer 
exposures to OGD and normoxia in calcium-free saline with oxidizing and reducing 
agents (Spaeth et al., 2011) should elucidate whether cytosolic oxidation has 
neuroprotective effects on OGD-induced plasmalemmal sealing.   
Conclusion  
In conclusion, the most disconcerting fact of current stroke treatment modalities is 
that none are capable of preventing massive loss of cells following reperfusion.  Our 
current preliminary study suggests that repair (sealing) of ischemia (OGD) induced 
plasmalemmal damage in murine B104 cells is similar to repair of transected neurites of 
B104 cells; which is similar to sealing in many invertebrate and vertebrate preparations 
(Spaeth, 2010).  These data suggest that sealing may be a universal mechanism regardless 
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of mode of plasmalemmal damage.  Thus, promoting endogenous plasmalemma repair 
factors (such as nPKC η and θ, PKA and Epac) before, during or after repurfusion may 
reduce loss of cells.  Continued research on proteins, such as nPKC η and θ (Chapter 2), 
PKA and Epac (Spaeth, 2010) and, molecular messengers, such as DAG (Chapter 2) or 
cAMP (Spaeth, 2010) that promote plasmalemmal sealing in vitro, under normoxic and 
hypoxic environments, should greatly and rapidly improve neuroprotective treatment 
modalities.  Such improvements should seriously diminish loss of cells and correlated 
behavioral functions, and improve overall recovery following a stroke. 
 
MATERIALS AND METHODS 
B104 cells: 
B104 cells derived from a CNS neuroblastoma (Bottenstein and Sato, 1979) have often 
been used as a model system to study neuronal function in vitro (Toda et al., 1999; Tan et 
al., 2003; Yoo et al., 2003, 2004; Nguyen et al., 2005; Miller et al., 2006; Spaeth et al., 
2010). B104 cells extend neurites that have properties typical of nerve axons such as 
generation of action potentials, smooth (but not rough) endoplasmic reticulum, release of 
neurotransmitter, and regeneration of severed neurites. Unlike some other model neuronal 
cell lines (e.g., PC12 cells), B104 cells do not require growth factor supplements of fetal 
bovine serum to proliferate (Detrait et al., 2000b; Yoo et al., 2003; Spaeth et al., 2010). 
Data on sealing of B104 cells are consistent with similar data on sealing from at least 19 




As described previously (Nguyen et al., 2005; Spaeth et al., 2010), B104 cells were 
grown in 75 cm
2
 vented cap flasks (BD Falcon; BD Biosciences) in a humidified 
incubator at 37°C in 5% CO2 and in 4 ml of cell growth medium: consisting of a 1:1 
mixture of Dulbecco’s modified Eagle’s medium and Ham’s F12 (DMEM:F-12, 
HyClone) supplemented for growth with 10% heat-inactivated fetal bovine serum (FBS; 
HyClone) and 1% antibiotics (10,000 U of penicillin/ml and 10 mg/ml streptomycin; 
Sigma-Aldrich). The cell growth medium was changed every 2 d. Cultures were passaged 
at 80% confluency, and cells were then either subcultured in a vented cap flask or seeded 
at ~2000 cells/cm 
2
 in cell growth media on Petri dishes coated with poly-D-lysine 
(Sigma-Aldrich) to prevent cells from detaching during solution changes and/or neurite 
transection.  After 24 h, the growth media was replaced with serum-free DMEM:F12 
(Hyclone) to allow the B104 cells to differentiate.  B104 cells were exposed to oxygen 
and/or glucose deprivation 24–48 h after replacing the cell growth media with serum-free 
DMEM:F12. 
 
Oxygen-Glucose Deprivation (OGD): 
For immediate OGD experiments, Petri dishes containing normoglycemic media 
(DMEM:F12) were placed inside an anaerobic vinyl-glove-box (Coy Laboratory 
Products, Grass Lake, MI) kept at 37°C.  Petri dishes were quickly rinsed twice with 
anoxic, hypoglycemic PBS
=
 (Hyclone). [Note: To ensure solutions were anoxic at start of 
OGD exposures, PBS
=
 and PKC peptide inhibitor solutions were maintained or created in 
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anaerobic vinyl-glove-box at least 24 h prior to experimentation.]  Immediately following 
rinses, cells were exposed to OGD for 1, 3, 5 or 10 minutes in PBS
=
.  Following OGD 
exposures, PBS
=





) or, sometimes with normoglycemic and 
normoxic PBS=, and all dishes were returned to a normoxic 37°C incubator. 
 
Assessment of dye exclusion: 
At 5 min after return to normoxic conditions we added Texas Red dextran (Molecular 
Probes, Eugene, OR; 3 kDa), to the PBS
2+
 or, sometimes PBS
=
, to assess the formation of 
a plasmalemmal seal using a Nikon TS100F inverted fluorescent microscope (Nikon 
Instruments Inc., Melville, NY) equipped with a rhodamine filter, at 60x magnification.  
Prior to observation, plates were rinsed twice with respective PBS solution.  Viable  B104 
cells (i.e., the cell must have an intact plasmalemma) exposed to OGD that exclude Texas 
Red dextran are counted as “sealed” and cells that do not exclude Texas Red dextran are 
counted as “not sealed” (Fig. 15F,G).  We consistently use a 3 kDa dye to standardize 
our comparisons of sealing between experimental and control treatments because higher 




Pharmacological agents (treatments) were dissolved in PBS
=
 (0 mM glucose), maintained 
in anaerobic chamber for at least 24 h prior to experimentation and, added to Petri dishes 
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to start OGD. To inhibit nPKC isozymes we used myristoylated nPKCη pseudosubstrate 
fragment (ηPSF; Spaeth, 2010), myristoylated nPKCθ pseudosubstrate fragment (θPSF; 
Staal et al., 2008; Barros, 2009), purchased from EMD Chemicals, Gibbstown, NJ. 
Statistical Analyses: 
We obtained dye exclusion data from many, individually-identifiable B104 cells that all 
received similar treatment (Normoxia or OGD) in a tightly controlled environment. To 
obtain sealing probabilities (%) for each treatment group, after a given exposure time, 
cell count data were pooled for all cells (n) from all Petri dishes (N).  See Table 5, for n 
and N values for each data set at each exposure time for all figures presented in this 
paper.  “Sealing probability” is defined as the percentage of cells that excluded 3 kDa 
Texas Red dextran dye (sealed) after a given exposure time. As described previously 
(Detrait, 2000b; Yoo , 2003, 2004; Spaeth, 2010; Chapter 2 and 3), the Cochran-Mantel-
Haenszel (CMH) χ
2
 test for independence was used to determine statistically significant 
differences between sealing probabilities of a given treatment exposure to normoxic 
control or, another treatment (*, p<0.05; **, p<0.01; ***, p<0.001).  GraphPad Prism4 
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Chapter 5: General Conclusions and Future Studies 
IMPORTANCE OF PLASMALEMMAL SEALING 
 Cells that do not repair (seal) plasma membrane (plasmalemmal) damage, do not 
survive (McNeil, 1993, 2000; Nguyen et al. 2005).  For victims of neurotrauma, such as 
peripheral nerve crush injury (PNCI) or stroke (plasmalemmal damage is produced by 
oxygen-glucose deprivation), loss of nerve cells (neurons) directly correlates with loss of 
functional behaviors and even paralysis.  Furthermore, in mammals, regaining lost 
functional behaviors is dependent upon axonal regeneration; which occurs from a 
surviving proximal axonal end that slowly grows neuritic processes at 1-2mm/day that 
often do not re-establish original synapses (Britt et al. 2010).  Thus, after PNCI or stroke, 
plasmalemmal sealing is a critical first step for neurons (Krause et al. 1994; Steinhardt et 
al. 1994; Bittner and Fishman, 2000; Detrait et al. 2000; Yoo et al. 2003; Spaeth et al. 
2010), because only surviving neurons are capable of axonal regeneration, which 
correlates with increased functional behavior recovery (Britt et al. 2010; Bittner et al. 
2012). 
 
GENERAL SUMMARY OF DISSERTATION RESULTS 
The goals of my dissertation research were as follows: (1) determine which PKC 
isozymes and their effectors, and whether DAG and other DAG-activated proteins are 
involved in plasmalemmal sealing (Chapter 2), (2) investigate whether inhibiting PKC- 
and PKA-dependent sealing could increase the probability of PEG-repair of PNCI 
following injury in physiologically relevant conditions, in a rat model (Chapter 3) and (3) 
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determine what role PKCs may have in sealing of ischemia-induced plasmalemmal 
damage in an in vitro model of stroke in B104 neurons (Chapter 4).  In the following 
paragraphs, I will briefly summarize the important results and conclusions presented in 
Chapters 2 – 4.  I will then briefly discuss future studies, some utilizing techniques other 
than dye exclusion, which should provide further insight on protein-protein interactions 
during sealing to better determine sealing pathways. 
Chapter 2 – Role of DAG, nPKC, MARCKS and Munc13-1 in sealing 
The first goal of my dissertation research was to determine which PKC isozymes 
and their effectors, and whether DAG and other DAG-activated proteins were involved in 
plasmalemmal sealing in mammalian neurons (B104 cells).  To determine how these 
proteins and substrates influenced sealing, I transected neurites of B104 cells in the 
presence of specific peptide inhibitors of PKC isozymes PKA, MARCKS and Munc13-1 
and small-molecule inhibitors of PKC, PLC, NSF and Golgi trafficking --sometimes in 
the presence of analogs of DAG or cAMP.   Data presented in Chapter 2 suggest that 
DAG increases sealing by activating MARCKS, and Munc 13-1, and that nPKCη, 
nPKCθ and PKA are all required to seal plasmalemmal damage (Fig. 8). 
Furthermore, data presented in Chapter 2 (also see, Zuzek et al. 2012), and 
previously reported data from B104 cells and data from many other eukaryotic 
preparations (see Supplementary Reference list in Spaeth et al. 2010) suggest that 
vesicle-mediated plasmalemmal sealing in eukaryotic cells, is an evolutionarily 
conserved process.  This sealing is induced by Ca
2+
 influx at plasmalemmal damage sites 
(Fishman and Bittner, 2003) and enhanced by increased cAMP concentration (Spaeth et 
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al. 2010) and DAG concentration and utilizes multiple vesicle-mediated pathways and 
membrane sources (Ballinger et al. 1997; Eddleman et al. 1997, 1998; Reddy et al. 2001; 





membrane fusion proteins, such as synaptobrevin, syntaxin, synaptophisin, 
synaptotagmin (Steinhardt et al. 1994; Detrait et al. 2000a,b; Yoo et al. 2003), Munc13-1 
(Zuzek et al. 2012) and, enzymes, such as PKA (Spaeth et al. 2010), nPKC η and θ 
(Zuzek et al. 2012) for formation and maintenance of a plasmalemmal seal (Fig. 8A, B). 
Data presented in Chapter 2 provide evidence of how PKCs and DAG influence 
plasmalemmal sealing in neurons in vitro.  Such insights have direct and indirect 
implications for axonal regeneration after traumatic injury (Bozkurt 2008; Bittner et al, 
2012) and for stroke in which neuronal membranes are damaged (Rodriguez-Sinovas et 
al. 2005).  For example, cells that do not seal plasmalemmal damage, do not survive 
(Nguyen et al. 2005).  Therefore, compounds that enhance endogenous sealing (OAG or 
db-cAMP) may be capable of rapidly promoting sealing of neurons damaged by 
traumatic injury or stroke, thereby greatly diminishing loss of behavioral function 
correlated with neurotrauma and stroke.  As a second example, compounds that inhibit 
endogenous sealing (nPKC or PKA peptide inhibitors) may be capable of enhancing 
polyethylene glycol (PEG) induced fusion of plasmalemmas, thereby greatly increasing 
the already profound effects of PEG on recovery of physiological and behavioral 
functions of crushed and/or severed peripheral nerves (Bittner et al. 2012).  Thus, a 
greater knowledge of proteins and substrates that influence plasmalemmal repair (sealing) 
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in vitro, should provide targets and substrates to improve neuroprotective treatment 
modalities. 
 
Chapter 3 – Trial and Error: Inhibiting nPKC’s and PKA do not increase the 
probability of PEG-fusing rat sciatic axons crushed in physiological calcium 
The second goal of my dissertation was to determine whether inhibiting PKC- and 
PKA-dependent sealing could increase the probability of PEG-repair of PNCI, following 
injury in physiologically relevant calcium concentration, in a rat model (Chapter 3).  Our 
current PEG-fusion protocol shown in Figure 3.2 relies on bathing sciatic nerves in 
hypotonic, calcium free physiological saline prior to and during crush, for successful 
PEG-fusions (Stavisky et al. 2005; Britt et al. 2010; Bittner et al. 2012).  In Chapter 3, I 
used an in vitro cell-based dye exclusion assay to determine whether compounds that 
inhibit Ca
2+
-induced plasmalemmal sealing in neuronal B104 cells in vitro (Fig. 11A) 
could be used to promote PEG-fusion of sciatic axons in vivo, following crush-severance 
in physiological calcium concentration (to realistically mimic peripheral nerve crush 
injury) (Table 3).  Only simultaneous inhibition of nPKC η, θ and PKA, dramatically 
decreased sealing when cells were transected in calcium in vitro (Fig. 11A, B).  Inhibitors 
of nPKC and PKA did not inhibit PEG-induced sealing in vitro (Fig. 11C, D).  However, 
when PEG was applied to cells transected in the combined presence of nPKC η, θ and 
PKA inhibitors, whether or not calcium was present during transection, all cells (intact 
and damaged) included Texas red dye suggesting that such treatment was cytotoxic in 
vitro (Fig. 11C, D).   
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Given these in vitro data, I carried on investigating whether nPKC η, θ and PKA 
inhibitor treatments could increase the probability of PEG-fusion following crush-
severance in physiological calcium concentration.  Data presented in Chapter 3 
conclusively show that applying inhibitors of nPKC and PKA (individually or in 
combination) to lesion sites immediately after crush-severance in Ca
2+
-containing 
physiological saline, but prior to PEG application, do not promote PEG-fusion as 
assessed by CAP conduction and dye diffusion through lesion sites (Table 3).   
As expected, PEG-fusions were always observed for all treatment groups in which 
PEG was applied to lesion sites immediately after crush-severance in hypotonic Ca
2+
-free 
physiological saline, as assessed by CAP conduction and dye diffusion through the lesion 
site (Table 2; Fig. 13).  That is, this study confirmed that successful PEG-fusions require 
that crushed axons are bathed in hypotonic Ca
2+
-free physiological saline, as previously 
reported in Stavisky et al. (2005), Britt et al. (2010) and Bittner et al. (2012). 
 
Chapter 4 – Preliminary Study: Role of nPKC η and θ in neuroprotective sealing of 
ischemia-induced plasmalemmal damage 
The third goal of my dissertation was to determine the roles of nPKC η and θ in 
sealing of ischemia-induced plasmalemmal damage.  I induced plasmalemmal damage in 
B104 cells by exposure to ischemic (oxygen and glucose deprivation; OGD) insult, 
sometimes in the presence of specific peptide inhibitors of nPKC isozymes η and θ, to 
determine the role of such nPKC isozymes in sealing of OGD-induced plasmalemmal 
damage.  Data presented in Chapter 4 show that inhibition of nPKC η or θ, during all 
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OGD exposures (1, 3, 5 or 10 min), decreased sealing probabilities compared to both 
normoxic control and cells exposed to OGD only (Table 6; Fig. 17).  Furthermore, 
exposing cells to OGD in the presence of both ηPSF + θPSF further decreased sealing 
probabilities compared to either inhibitor alone [but proved toxic after only 5 minutes of 
exposure to OGD and ηPSF + θPSF].  These data suggest that nPKC η and θ promote 
sealing of OGD-induced plasmalemmal damage in B104 cells.  Furthermore, our data 
suggest that sealing of plasmalemmal damage in B104 cells, whether transection- 
(Spaeth, 2010; Chapter 2) or OGD-induced, occurs via a universal mechanism that 
requires nPKC η and θ. 
General Conclusion on Dissertation Results 
In conclusion, continued research on proteins, such as nPKC η and θ (Chapter 2), 
PKA and Epac (Spaeth, 2010) and, molecular messengers, such as DAG (Chapter 2) or 
cAMP (Spaeth, 2010) that promote plasmalemmal sealing in vitro, under normoxic 
(neurite transection) and hypoxic (stroke) environments, should greatly and rapidly 
improve neuroprotective treatment modalities.  Such improvements should seriously 
diminish loss of cells and correlated behavioral functions, and improve overall recovery 
following a stroke. 
Future studies on plasmalemmal sealing should focus on determining protein-
protein interactions to better resolve sealing pathways, and provide more accurate targets 
for therapeutic treatment modalities. 
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FUTURE STUDIES 
Testing different [cAMP] in ηPSF+θPSF to begin to determine if nPKC negatively 
feedbacks on PKA in B104 cells  
In Chapter 2, Figure 4D, we unexpectedly observed that addition of db-cAMP to 
ηPSF+θPSF significantly decreased sealing compared to ηPSF+θPSF alone.  These data 
suggest that DAG-PKC and cAMP-PKA sealing pathways not only converge, but may 
interact in a feedback loop.  That is, a decrease in nPKC activity (produced by nPKC 
inhibitors) in the presence of increased cAMP during plasmalemmal sealing, initiates 
negative feedback on PKA-dependent sealing pathways.  Such a feedback loop would 
decrease the activity of those sealing pathways not blocked by nPKC inhibitors, such as 
PKA, and would further decrease sealing compared to ηPSF+θPSF alone, as seen in 
Figure 4D. 
A preliminary study to determine whether such a feedback loop exists could be 
performed by using our current dye exclusion protocol on transected B104 cells: cells 
would be transected in ηPSF+θPSF, and differing concentrations of db-cAMP (1mM was 
used in Chapter 2, and Zuzek et al. 2012).  If the aforementioned feedback loop does 
exist, decreasing [cAMP] in ηPSF+θPSF should promote sealing to levels similar to 
ηPSF+θPSF alone; however, increasing [cAMP] even more (>1mM) in ηPSF+θPSF 
should further decrease sealing compared to ηPSF+θPSF alone by increasing negative 
feedback on PKA.  If feedback loop does not exist, increasing [cAMP] greater than 1mM 
in ηPSF+θPSF should increase sealing, suggesting that the previously used [cAMP] was 
not high enough to overcome ηPSF+θPSF.  Possible pitfalls include the following: 
increasing [cAMP] higher than 1mM may be cytotoxic and, increasing [cAMP] may have 
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no affect at all, suggesting the current concentration is the maximum effective 
concentration.  Taken together, performing a db-cAMP dose response curve on sealing in 
B104 cells would be advantageous in determining whether or not increased or decreased 
cAMP concentrations have differing effects on sealing compared to 1mM db-cAMP. 
 
Protein Kinase D and Ras guanyl nucleotide releasing protein1 
 Like nPKC isozymes and Munc13-1, protein kinase D (PKD) and Ras guanyl 
nucleotide releasing protein1 (RasGRP) also contain the DAG binding C1 domain (Brose 
and Rosenmund, 2002).  Like most of the targets studied in this dissertation, PKD and 
RasGRP are involved in constitutive vesicle trafficking, and interact with nPKCη and 
nPKCθ, respectively (Carrasco and Merida, 2004; Diaz-Anel and Malhotra, 2005). 
Firstly, western blotting should be performed to determine whether PKD and 
RasGRP are expressed by B104 cells.  Secondly, to determine if PKD or RasGRP 
influence sealing, B104 cells would be transected in inhibitors of PKD or RasGRP, and 
dye exclusion would be assessed at various PC times to determine the effect of such 
inhibitors on sealing probability and rate (as was done in Chapter 2 for inhibitors of 
nPKC, PLC, Munc13-1, MARCKS, etc).  Inhibitors of PKD and RasGRP should 
decrease sealing, suggesting that PKD and RasGRP promote sealing in B104 cells, and 
likely all other eukaryotic cells. 
Considering the known interactions between PKD and RasGRP with nPKCη and 
nPKCθ (Carrasco and Merida, 2004; Diaz-Anel and Malhotra, 2005), such data should be 
a catalyst to employ techniques that would better resolve protein-protein interactions in 
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B104 and other eukaryotic cells during sealing.  Because, our current protocol of dye 
exclusion cannot explicitly distinguish protein interactions. 
 
Fluorescence Resonance Energy Transmission (FRET): A microscopy method for 
confirming protein interactions from past and future sealing studies 
Our current protocol, dye exclusion, does not provide evidence of protein 
interactions.  To better resolve sealing pathways, imaging techniques, such as FRET, 
should be used to determine whether hypothetical interactions exist in future sealing 
studies; and retroactively to confirm previously hypothesized interactions as well.  FRET 
is a fluorescence imaging technique that relies on energy transfer from one excited 
fluorophore (donor) to a second (different) fluorophore (acceptor) in close proximity (10 
nm, or 100 angstroms).  FRET does require that a cell be stably transfected and express 
fluorophore conjugated proteins.  Thus, if the proteins conjugated to the donor and 
acceptor fluorophores do interact, the typical result is quenching of the donor fluorophore 
and increased emission from the acceptor fluorophore.  An alternative FRET approach is 
loss of FRET upon interaction, typically caused by phosphorylation of a target protein 
(causing allosteric changes in protein structure) that undergoes FRET in its 
unphosphorylated state (Redden et al. 2012).  This latter approach to FRET could be very 
useful for determining PKC and PKA interactions in sealing pathways. 
As mentioned above, current dye exclusion data suggest that nPKC and PKA may 
interact in a negative feedback loop (Fig. 4D, Chapter 2).  Both PKA and PKC interact 
with A-kinase anchoring protein (AKAP), and AKAP7 binds both active and inactive 
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PKC isozymes (Redden et al. 2012).  Some AKAPs are inhibitory, that is, binding of a 
catalytically active enzyme to such an AKAP, like AKAP12, decreases its activity 
(Redden et al. 2012).  Of interest for future studies would be to conjugate nPKC η and θ, 
and PKA to respective fluorophores (e.g. PKCs = donors; and PKA acceptor), and 
observe FRET during sealing.  Furthermore, such studies should also include observing 
FRET in the presence or absence of nPKC or PKA specific peptide inhibitors, and 
exogenously increased cAMP.  Such conditions would provide further evidence of 
interaction between nPKCs and PKA, and whether decreased nPKC activity negatively 
feedbacks on PKA, likely through AKAP. 
Of particular interest for sealing studies employing FRET is the use of an 
alternative FRET approach: loss of FRET in target protein upon phosphorylation by an 
active kinase.  One such method is the use of CKAR, a target peptide for active PKC and 
thus, a reporter of PKC activity (Redden et al. 2012).  In Redden et al. (2012), CKAR 
was conjugated to AKAP7 to determine whether PKC interacted with AKAP7; loss of 
FRET in CKAR was observed when PKC was stimulated.  A similar approach could be 
employed with regards to PKA and nPKC η and θ: here only CKAR and similar peptide 
target for PKA would be conjugated to an AKAP (likely AKAP7).  Under such 
conditions, loss of FRET from CKAR or PKA’s target peptide conjugated to an AKAP 
would be evidence of direct interaction between nPKC η and θ or PKA at an AKAP.  
Furthermore, analogous experiments could employ truncated versions of AKAPs (AKAP 
fragments), which can be used as selective peptide inhibitors to inhibit binding of PKCs 
and PKA to AKAP (Redden et al. 2012).  Data from these analogous experiments should 
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provide further evidence of which AKAP both nPKC η and θ, and PKA interact with 
(i.e., in the presence of AKAP fragments, CKAR FRET should be expected, even when 
PKC is stimulated).. Taken together, data collected from FRET studies during sealing 
would provide evidence of whether nPKCs and PKA interact at specific AKAPs, and 
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Appendix Figure A1:  
(A) Effect of 0.7 or 7.0μM ηPSF on sealing. 
(B) Effect of 0.09, 0.9 or 9.0μM θPSF on sealing. 
(C) Effect of 0.1, 1.0 or 10.0μM Bisindoylmaleimide 1 (Bis1) on sealing. 
(D) Effect of 8 or 16μM U73122 or, inactive analog of U73122, U73343, on sealing. 
Significance levels for this figure are indicated with asterisks: no symbol, p>0.95; ***, 
p≤0.001. 
 
We tested the following compounds to insure that we were using appropriate 
concentrations to affect sealing in B104 cells: nPKC pseudosubstrate fragments η and θ 
PSF, reported use of such PSFs in micromolar concentrations (ηPSF, Spaeth et al. 2010; 
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θPSF, Staal et al. 2008; Barros et al. 2009); Bisindoylmaleimide (Bis 1), reported use in 
nanomolar concentrations to inhibit PKCs (Togo, 2004); U73122 in micromolar 
concentrations to inhibit phospholipase C (PLC) activity and for a negative control, we 
used the inactive analog of U73122, U73343 in similar concentrations (Bleasdale et al. 
1990; Hildebrandt et al. 1997; Tanaka et al. 2003). [The Methods section, 
Pharmacological Reagents, states the concentrations used and the primary references for 
the use of these concentrations.]  To determine the best concentration for inhibition of 
plasmalemmal sealing, we employed two assays:  
1) A dye exclusion assay (see Methods) to assess sealing in cells with transected 
neurites (data shown, see Results and Online Resource 1) exposed to differing 
concentrations of compounds. As stated above, this Figure can be moved to the main 
text. 
2) A cytotoxicity assay (data not shown) in which intact B104 cells were exposed to 
differing concentrations of a compound for 10 minutes in Ca
2+
-free saline (to mimic 
exposure time during transection), meanwhile we looked for changes in morphology 
of intact cells, dye inclusion in intact cells, or cell death.  If a specific concentration 
of a compound caused cytotoxic effects, that concentration was not used in dye 
exclusion experiments.  The following compounds, db-cAMP, PKA, Brefeldin A 
and NEM, have all been previously reported to effect sealing in B104 cells (Spaeth 
et al. 2010, 2011 a, b). 
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used in our study 





nPKC inhibitors    
η PSF 7 µM Liu, 2006; Barros, 2009 2 and 20 µM 
θ PSF 9 µM Staal, 2008; Barros, 2009 2 and 10 µM 
cPKC inhibitors    
20-28 PSF 8 µM 
Liu, 2006; Jungnickel, 2007; Ratz and 
Miner, 2009 
10 and 20 µM 
Gö6976 1 µM Togo, 1999 and 2006 1 µM 
Bis1 0.1, 1 and 10 µM Togo, 1999 0.5  µM 
PLC inhibitors    
U73122 16 µM 
Bleasdale, 1990: Hildebrandt, 1997; 
Tanaka, 2003 
10 and 20 µM 
U73343 (inactive 
analog of U73122) 
16 µM 
Bleasdale, 1990; Hildebrandt, 1997; 
Tanaka, 2003 
10 and 20 µM 
DAG analog    
OAG 100 µM 
Doherty, 1995; Wang and Oram, 2007; 
Ju, 2010 
10, 50, 100 µM 
PKA inhibitor    
PKI 50 µM Spaeth, 2010 50 µM 
PKA activator    
db-cAMP 1 mM Spaeth 2010 1 mM 
MARCKS 
inhibitor 
   
BIO-11006 
(peptide) 
100 µM Agrawal, 2007; Damera, 2010 100 µM 
Munc13-1 
inhibitor 
   
Mid-protein 100 µM Mochida, 1998 125 µM 
NSF inhibitor    
NEM 1 mM Rodriguez, 1994; Spaeth 2011 1 or 3 mM 
Golgi traffic 
inhibitor 
   
Brefeldin A 10  µM 
Togo and Steinhardt, 2003; Spaeth 
2011 
50  µM 
PSF = pseudosubstrate fragment. 
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Appendix Table B: Number of plates and transected B104 cells per PC time point 
Treatment PC time (min) 
1 2.5 5 10 20 
Control  (2, 99) (2, 108) (4, 258) (5, 64) (6, 286) 
DMSO     (8, 209) (3, 102) (6, 202) 
η PSF     (3, 108) (3, 53) (3, 99) 
θ PSF     (2, 85) (3, 125) (3, 115) 
η PSF + θ PSF   (2, 174) (2, 246)   (2, 167) 
20-28 PSF     (2, 130) (3, 81) (3, 113) 
Go6976     (3, 109) (5, 102) (3, 88) 
Bis1 100 nM     (3, 101) (3, 90) (3, 95) 
Bis1 1 µM     (3, 126) (3, 78) (3, 154) 
U73122 (2, 139)   (2, 157) (3, 136) (2, 118) 
U73343   (2, 99) (3, 134) (2, 96) (3, 124) 
OAG   (2, 122) (2, 172)   (2, 241) 
OAG no Ca
2+ 
 (2, 145) (4, 263)  (1, 89) 
U73122 + OAG   (2, 122) (2, 182)   (2, 120) 
MARCKSpi   (2, 121) (2, 168)   (2, 208) 
MARCKSpi + OAG   (2, 88) (2, 182)   (2, 208) 
NEM   (3, 134) (3, 180)    (3, 128) 
NEM + OAG   (2, 140) (4, 318)   (2, 134) 
PKI   (2, 112) (3, 113)   (3, 121) 
NEM + PKI   (2, 273) (2, 169)   (2, 204) 
PKI + OAG   (2, 235) (2, 141)   (2, 112) 
θ PSF + OAG   (2, 163) (2, 136)   (2, 143) 
η PSF + OAG   (2, 211) (2, 286)   (2, 148) 
η PSF + θ PSF + OAG   (2, 176) (2, 182)   (2, 214) 
db-cAMP   (2, 107) (2, 112)   (2, 120) 
θ PSF + db-cAMP   (2, 109) (2, 130)   (1, 98) 
η PSF + db-cAMP   (2, 108) (2, 102)   (1, 127) 
η PSF + θ PSF + db-cAMP   (2, 357) (2, 225)   (1, 115) 
η PSF + θ PSF + PKI (PBS
2+
)   (2, 147) (2, 134)   (2, 114) 
η PSF + θ PSF + PKI   (2, 137) (2, 116)   (2, 144) 
η PSF + θ PSF + PKI + OAG (PBS
2+
)   (2, 114) (2, 134)   (2, 122) 
η PSF + θ PSF + PKI + OAG   (2, 107) (2, 116)   (2, 116) 
η PSF + θ PSF + PKI + db-cAMP (PBS
2+
)   (2, 121) (2, 143)   (2, 182) 
η PSF + θ PSF + PKI + db-cAMP   (2, 137) (2, 118)   (2, 144) 
Bref-A   (1, 75) (2, 161)   (2, 159) 
Bref-A + OAG   (2, 160) (4, 504)   (3, 354) 
Munc-pi   (2, 202) (2, 194)   (2, 225) 
Munc-pi + OAG   (2, 191) (2, 138)   (2, 227) 
Munc-pi + db-cAMP   (2, 180) (2, 168)   (2, 245) 
Munc-pi scramble   (2, 241) (2, 222)   (2, 236) 
Munc-pi scramble + OAG   (2, 202) (2, 106)   (2, 206) 
Munc-pi scramble + db-cAMP   (2, 194) (2, 208)   (2, 159) 
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Table B:  The numbers in parentheses (N, n) represent the number of Petri dishes (N) 
used to obtain sealing data from (n) transected B104 cells.  The total number of cells (n) 
listed per condition was obtained by combining the sum of all cells counted (sealed or not 
sealed) from each dish per condition at a given PC time.  Blank space: no experiments 
performed for condition at designated PC time.  (PBS
2+
) indicates neurites were 
transected in Ca
2+
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